ILD, hospital admissions 1, main diag only

ILD_HOSPITAL_MAIN

interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Main diagnosis only: side diagnoses are not checked. Registry filters: Hospital discharge: ICD-10 — J84 Hospital discharge: ICD-9 — 515\|516 Hospital discharge: ICD-8 — 48499\|51701 1 out of 7 registries used, show all original rules.	5645
4. Check minimum number of events None	5645
5. Include endpoints None	5645
6. Filter based on genotype QC (FinnGen only)	5490

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J80-J84
Name in latin: Alii morbi interstitiales pulmonum

NAME	ILD_HOSPITAL_MAIN
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY	YES
HD_ICD_10_ATC
HD_ICD_10	J84
HD_ICD_9	515\|516
HD_ICD_8	48499\|51701
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to ILD, hospital admissions 1, main diag only based on the number of shared cases.

Similar with more cases:

Similar with less cases:

ILD medications: nintedanib

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5490	2249	3241
Unadjusted period prevalence (%)	1.20	0.80	1.48
Median age at first event (years)	69.71	67.30	71.38

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5645: Matched controls
56450

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

XG410

NOMESCO Finland

Flow-volume spirometry

8.7

307.7

810

1068

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

876.3

307.7

3129

GD1AD

NOMESCO Finland

Thorax CT examination

7.0

307.7

1083

1846

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

24.2

307.7

2060

1311

R06.0

ICD-10 Finland

Dyspnoea

3.2

307.7

2490

11246

L04AX01

ATC

azathioprine; systemic

8.0

307.7

663

924

L04AA06

ATC

mycophenolic acid; systemic

15.9

307.7

441

299

J96.1

ICD-10 Finland

Chronic respiratory failure

8.8

307.7

480

593

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

34.3

307.7

259

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.9

307.7

1341

3383

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

530.8

307.7

2724

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

26.6

307.7

324

129

TGC00

NOMESCO Finland

Bronchial lavation

34.3

307.7

1342

509

356

Kela drug reimbursment

Nintedanib and pirfenidone

6436.7

307.7

589

UGC12

NOMESCO Finland

Flexible bronchoscopy

11.1

307.7

2042

2752

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.7

307.7

3961

22086

H02AB06

ATC

prednisolone; systemic

5.5

307.7

4290

20670

L04AX05

ATC

pirfenidone; oral

4033.3

307.7

387

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

17.4

307.7

963

658

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

7.9

307.7

2114

3960

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

10.1

307.7

631

692

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

75.9

307.7

240

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.5

307.7

897

1603

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.2

307.7

2963

11836

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

909.6

307.7

1712

284

Kela drug reimbursment

Nintedanib and pirfenidone

6672.7

307.7

608

L01EX09

ATC

nintedanib; oral

2899.5

298.3

286

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.8

290.1

729

1708

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.6

273.7

705

1682

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.6

271.1

2696

14527

Z94.2

ICD-10 Finland

Lung transplant status

90.4

269.0

141

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.0

267.2

876

2503

R03AC02

ATC

salbutamol; inhalant

2.6

259.6

3525

21889

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.3

233.0

1011

3457

P01BA02

ATC

hydroxychloroquine; oral

3.8

231.9

785

2283

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.4

217.9

597

1486

L01XE31

ATC

[U] nintedanib

+∞

217.1

207

J01MA14

ATC

moxifloxacin; systemic

3.4

214.1

897

2992

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.0

194.1

607

1662

GX1D5

NOMESCO Finland

Flow volume spirometry

46.0

176.8

104

GX1K5

NOMESCO Finland

Diffusion capacity

17.6

172.5

141

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

19.4

170.4

133

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

848.3

168.7

165

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

5.3

159.5

331

652

A02BC02

ATC

pantoprazole; systemic

2.3

158.8

4237

31905

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.4

156.3

420

1024

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

9.7

154.1

182

194

M05BA04

ATC

alendronic acid; oral

2.9

150.8

814

3108

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

149.2

1443

7283

R03BB04

ATC

tiotropium bromide; inhalant

2.6

147.4

987

4209

R05

ICD-10 Finland

Cough

2.3

142.3

1487

7730

48499

ICD-8 Finland

Acute interstitial pneumonia

705.6

140.5

138

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

7.6

139.9

202

276

C03CA01

ATC

furosemide; systemic

2.0

138.8

2522

16131

L04AA13

ATC

[U] leflunomide

5.5

131.4

262

497

XX4BW, ,

NOMESCO Finland

50.0

128.0

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

9.5

127.2

151

162

GDG10

NOMESCO Finland

Bilateral transplantation of lung

216.5

123.2

127

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

121.5

1286

6665

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

314.4

120.7

122

L04AX03

ATC

methotrexate; systemic

2.8

118.5

688

2712

A07EC01

ATC

sulfasalazine; oral, rectal

2.9

116.0

605

2253

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

8.7

115.8

147

172

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.1

115.2

529

1834

127

Kela drug reimbursment

Transplant complication

7.1

115.1

175

253

J47

ICD-10 Finland

Bronchiectasis

5.1

113.9

248

508

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

112.4

893

4087

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.2

109.7

305

760

L01BA01

ATC

methotrexate; systemic

3.9

108.7

334

895

WX721

NOMESCO Finland

Oxygen concentrator therapy

21.9

108.1

L04AD01

ATC

ciclosporin; systemic

6.0

107.2

193

332

R02

ICPC

Shortness of breath/dyspnoea

2.3

107.1

987

4809

J01MA12

ATC

levofloxacin; systemic

2.0

103.5

1379

7737

R03BA08

ATC

ciclesonide; inhalant

2.7

103.3

600

2359

J43.9

ICD-10 Finland

Emphysema, unspecified

5.2

101.7

212

418

R03AK08

ATC

formoterol and beclometasone; inhalant

3.6

101.3

357

1050

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.9

100.9

227

478

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

34.8

98.1

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

95.1

1400

8102

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

94.8

1691

10427

ZX108

NOMESCO Finland

Inhalation

9.2

93.8

114

126

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.9

93.3

210

442

WX892

NOMESCO Finland

Monitored bed care

2.5

93.0

628

2654

R4110

NOMESCO Finland

Physiotherapy

1.9

91.7

1757

11060

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

9.8

91.4

106

110

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

5.3

89.7

185

361

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

231.2

88.7

WW200

NOMESCO Finland

Immunization

4.2

88.6

241

590

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

15.7

88.0

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

86.2

1457

8785

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

7.2

85.8

129

184

R50.9

ICD-10 Finland

Fever, unspecified

2.1

85.4

999

5303

R99

ICPC

Respiratory disease other

4.7

85.4

200

435

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.8

84.6

457

1725

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

9.2

82.0

100

111

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.2

81.7

223

547

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

81.2

1891

12527

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.4

81.2

206

478

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

80.4

1207

6978

XG466

NOMESCO Finland

Sleep oxymetry

3.5

80.3

281

821

R04.2

ICD-10 Finland

Haemoptysis

3.1

80.1

358

1216

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.3

79.8

308

958

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

77.8

1381

8416

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

77.6

1701

11041

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.4

77.4

572

2512

L88

ICPC

Rheumatoid/seropositive arthritis

3.3

75.7

304

969

R81

ICPC

Pneumonia

3.2

75.3

315

1029

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.8

74.6

403

1519

J01AA02

ATC

doxycycline; systemic

1.8

74.5

4347

36613

L04AD02

ATC

tacrolimus; systemic

7.9

74.4

102

131

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

74.3

2734

20353

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.5

71.4

258

769

GDA10

NOMESCO Finland

Biopsy of lung

16.4

71.0

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

70.5

1142

6735

J01FA06

ATC

roxithromycin; oral

1.7

69.2

2215

15820

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

69.0

451

1868

R28

ICPC

Limited function/disability (R)

4.8

67.4

154

328

XX9XE

NOMESCO Finland

Other ultrasound examination

7.5

66.9

130

GX2C5

NOMESCO Finland

Short-lasting oximetry

10.1

66.4

H02AB07

ATC

prednisone; oral

2.0

65.9

896

4978

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

6.2

65.6

113

186

R05

ICPC

Cough

1.8

65.2

1337

8443

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

18.1

64.6

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

64.3

493

2194

WX726

NOMESCO Finland

High-flow oxygen therapy

18.7

63.0

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

62.3

811

4433

F1246, ,

NOMESCO Finland

19.0

62.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

61.1

1040

6198

N02AA01

ATC

morphine; systemic, rectal

3.8

61.1

193

526

D86.0

ICD-10 Finland

Sarcoidosis of lung

5.5

60.6

119

222

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

13.5

59.6

L04AA01

ATC

[U] ciclosporin

5.0

58.3

126

256

ZXE00

NOMESCO Finland

One hour or less

1.6

57.9

2146

15700

J01CA04

ATC

amoxicillin; systemic

1.7

57.1

4250

36494

Z3226

NOMESCO Finland

Physiotherapist

1.8

55.7

1097

6808

L04AA24

ATC

abatacept; parenteral

11.3

55.3

ZX120

NOMESCO Finland

Intravenous

2.0

54.9

624

3242

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.1

54.8

154

386

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

20.1

54.7

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.4

54.6

399

1735

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.5

54.3

193

569

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

54.1

1950

14114

XX2RW, ,

NOMESCO Finland

5.4

54.0

108

205

J43.8

ICD-10 Finland

Other emphysema

9.6

53.9

N02AX02

ATC

tramadol; systemic, rectal

1.5

53.8

2479

18956

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

53.3

887

5229

M05BA07

ATC

risedronic acid; oral

3.0

52.5

241

829

L04AB01

ATC

etanercept; parenteral

5.0

52.3

112

226

M01CB01

ATC

sodium aurothiomalate; parenteral

4.6

52.2

126

281

F2680, ,

NOMESCO Finland

14.5

51.0

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

7.5

50.8

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.5

50.3

175

509

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

50.2

821

4809

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

50.0

763

4374

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

10.5

49.9

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.7

49.6

120

Z2221

NOMESCO Finland

Medical doctor

1.6

49.5

1492

10308

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

48.4

1024

6455

A02BC01

ATC

omeprazole; systemic

1.6

48.3

1613

11405

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

48.2

608

3270

Z3231

NOMESCO Finland

Registered nurse

1.6

48.0

1588

11199

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.5

48.0

166

481

M34.1

ICD-10 Finland

CR(E)ST syndrome

8.9

47.5

XJC10

NOMESCO Finland

Oesophageal pH monitoring

7.4

46.6

A02BC05

ATC

esomeprazole; systemic

1.5

46.3

2189

16668

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

46.2

640

3551

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

46.0

1661

11926

J84

ICD-10 Finland

Other interstitial pulmonary diseases

236.9

46.0

J80

ICD-10 Finland

Adult respiratory distress syndrome

8.7

45.2

J12.8

ICD-10 Finland

Other viral pneumonia

5.3

45.2

174

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

45.1

656

3697

Z51.5

ICD-10 Finland

Palliative care

1.9

44.5

603

3319

C07AB07

ATC

bisoprolol; oral

1.5

44.4

3052

24988

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.7

44.2

141

387

A07AA02

ATC

nystatin; oral

2.2

42.5

397

1910

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.1

42.3

184

614

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

41.9

478

2479

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

41.9

1113

7415

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

41.8

772

4668

J92.9

ICD-10 Finland

Pleural plaque without asbestos

4.0

41.8

121

310

JN4AD

NOMESCO Finland

Body CT examination

1.8

41.7

682

3980

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

40.8

737

4427

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

7.0

40.6

WZC30

NOMESCO Finland

Teaching

1.7

40.3

910

5812

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

59.2

40.3

XPX04

NOMESCO Finland

Angioscopy

10.8

40.0

R03BA02

ATC

budesonide; inhalant

1.7

39.5

912

5854

I50.0

ICD-10 Finland

Congestive heart failure

1.8

38.9

585

3323

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

10.1

38.9

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

38.8

615

3551

A03

ICPC

Fever

1.8

38.6

704

4236

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.6

38.6

224

873

R03BA01

ATC

beclometasone; inhalant

1.7

38.4

775

4798

L04AB04

ATC

adalimumab; parenteral

3.8

38.4

120

325

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

38.1

1209

8373

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.2

38.0

101

243

J01FA10

ATC

azithromycin; systemic

1.4

38.0

2562

20654

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

37.6

297

1334

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

5.4

37.5

139

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

37.4

276

1203

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

37.4

421

2171

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

37.2

2302

18243

G47.3

ICD-10 Finland

Sleep apnoea

1.6

36.9

1176

8145

J43.2

ICD-10 Finland

Centrilobular emphysema

7.3

36.8

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

36.8

269

1168

WZA10

NOMESCO Finland

Extensive medical or dental certificate

4.4

36.7

216

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.0

36.5

166

568

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

8.5

36.4

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

10.3

36.0

M34.0

ICD-10 Finland

Progressive systemic sclerosis

13.8

35.6

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

35.6

992

6654

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.7

35.2

174

Z57.2

ICD-10 Finland

Occupational exposure to dust

6.9

35.1

D07AC01

ATC

betamethasone; topical

1.4

34.4

1892

14608

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

34.2

506

2857

J96.0

ICD-10 Finland

Acute respiratory failure

3.5

34.1

120

352

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.7

34.0

771

4911

L01AA01

ATC

cyclophosphamide; systemic

6.1

34.0

GD2SN

NOMESCO Finland

Lung ventilation SPECT

5.0

34.0

148

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.4

33.7

123

369

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

33.5

428

2304

R03BA05

ATC

fluticasone; inhalant

1.6

33.4

898

5964

E0000UV, ,

ATC

1.4

33.2

2072

16344

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

32.7

314

1525

J94.1

ICD-10 Finland

Fibrothorax

49.1

32.5

R06AE07

ATC

cetirizine; oral

1.4

32.0

1997

15725

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

3.9

31.8

245

J01FF01

ATC

clindamycin; systemic

1.5

31.7

1394

10285

J20

ICD-10 Finland

Acute bronchitis

1.8

31.4

513

2982

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

31.4

286

1361

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

3.2

31.2

127

408

A02BC03

ATC

lansoprazole; oral

1.4

31.2

1570

11879

GX2D5

NOMESCO Finland

Sleep oximetry

6.0

31.0

M05.1

ICD-10 Finland

Rheumatoid lung disease

70.3

30.9

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

85.6

30.7

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

30.6

384

2052

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

31.0

30.3

WX722

NOMESCO Finland

PEEP

2.1

30.1

290

1410

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

3.0

30.0

131

439

M35.1

ICD-10 Finland

Other overlap syndromes

6.3

29.9

J99.0

ICD-10 Finland

Rheumatoid lung disease

304.0

29.8

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

4.5

29.6

158

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.5

29.5

105

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.8

29.3

241

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

29.2

397

2180

XG460

NOMESCO Finland

Short time oxymetry

3.0

29.0

126

421

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

6.5

28.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

28.8

375

2029

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

9.8

28.5

J67.0

ICD-10 Finland

Farmer lung

10.1

28.3

M33.2

ICD-10 Finland

Polymyositis

8.3

28.2

2AX04, ,

NOMESCO Finland

78.0

27.8

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

27.7

1913

15232

GAA31

NOMESCO Finland

Thoracoscopy

6.1

27.5

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.5

27.5

147

TGD00

NOMESCO Finland

Needle biopsy of lung

5.2

27.3

109

J01DB01

ATC

cefalexin; oral

1.4

27.3

4284

38849

M04AA01

ATC

allopurinol; systemic

1.5

27.3

900

6237

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

27.2

706

4634

AN1

Coronary angiography

1.6

27.0

775

5206

JN4BD

NOMESCO Finland

Extensive body CT

1.6

27.0

640

4110

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

26.9

1974

15850

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.4

26.9

280

R03DC03

ATC

montelukast; oral

1.6

26.7

724

4800

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

26.7

1617

12577

SPAT1325

SPAT

Vaccination

1.4

26.6

1927

15433

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.4

26.6

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

26.4

264

1301

J05AB11

ATC

valaciclovir; oral

1.6

26.4

696

4585

Z2446

NOMESCO Finland

Social worker

1.9

26.3

323

1713

L04AC07

ATC

tocilizumab; parenteral

8.7

26.3

N02BE01

ATC

paracetamol; systemic, rectal

1.5

26.2

4768

44217

J01FA09

ATC

clarithromycin; systemic

1.4

26.1

1385

10517

A01AB09

ATC

miconazole; local oral

1.7

26.1

467

2783

1XC02, ,

NOMESCO Finland

4.5

25.9

138

5BA08, ,

NOMESCO Finland

5.1

25.6

104

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

25.4

1262

9463

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

25.4

1766

14026

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

25.4

2008

16278

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

25.4

554

3482

C01DA14

ATC

isosorbide mononitrate; oral

1.5

25.3

1115

8177

H02AB04

ATC

methylprednisolone; systemic

1.6

25.3

739

4981

J15.8

ICD-10 Finland

Other bacterial pneumonia

4.1

25.3

170

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

25.2

333

1809

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

25.2

2251

18590

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.3

25.0

186

814

N03AX16

ATC

[U] pregabalin

1.4

24.9

1201

8956

R06.2

ICD-10 Finland

Wheezing

2.1

24.8

231

1109

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

90.5

24.7

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.8

24.6

371

2102

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

7.5

24.6

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

24.5

3391

29822

J01FA15

ATC

telithromycin; oral

1.7

24.5

453

2723

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

24.5

246

1215

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.9

24.5

183

RK320, ,

NOMESCO Finland

3.9

24.4

179

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.2

24.4

211

984

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

24.3

800

5533

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.5

24.2

129

R01AD09

ATC

mometasone; nasal

1.4

24.0

1953

15862

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

29.2

24.0

R4190

NOMESCO Finland

Nutritional therapy

2.3

24.0

182

803

SPAT1262

SPAT

Handing over of treatment supplies

1.5

24.0

1025

7467

J98.4

ICD-10 Finland

Other disorders of lung

8.0

23.9

XG405

NOMESCO Finland

Education on PEF monitoring

3.1

23.7

101

334

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.6

23.5

124

N02AA05

ATC

oxycodone; systemic

1.4

23.5

1078

7952

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

23.5

632

4175

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.4

23.5

160

674

5AB14, ,

NOMESCO Finland

19.6

23.4

I73.0

ICD-10 Finland

Raynaud syndrome

3.3

23.3

266

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

23.2

952

6875

RK110, ,

NOMESCO Finland

4.1

23.2

159

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

8.4

23.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

23.0

1327

10187

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

22.8

329

1838

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

22.8

143

580

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

22.7

284

1515

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

22.6

111

398

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.2

22.5

287

J93.8

ICD-10 Finland

Other pneumothorax

4.9

22.4

101

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

22.3

475

2964

318

Kela drug reimbursment

Teriparatide

4.8

22.2

102

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

4.7

22.1

110

5169X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy

+∞

21.9

5163A

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis

+∞

21.9

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

21.9

1969

16179

ZXA10

NOMESCO Finland

Bilateral

1.4

21.8

1009

7447

UJF32

NOMESCO Finland

Coloscopy

1.4

21.8

1448

11363

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.4

21.7

120

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

6.7

21.7

M31.3

ICD-10 Finland

Wegener granulomatosis

6.0

21.6

3A006, ,

NOMESCO Finland

220.8

21.6

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

21.5

436

2686

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

1.9

21.5

259

1366

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

3.6

21.2

188

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.4

21.2

150

643

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.6

21.2

193

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.4

21.2

148

631

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

21.0

223

1124

R29

ICPC

Respiratory symptom/complaint other

1.8

21.0

324

1847

ZXA00

NOMESCO Finland

Right side

1.4

20.9

1459

11520

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

20.9

927

6782

J45.8

ICD-10 Finland

Mixed asthma

2.2

20.9

172

787

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

20.8

1388

10881

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

20.8

323

1846

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

20.7

1241

9564

D07AC13

ATC

mometasone; topical

1.4

20.7

1400

11001

N05CF01

ATC

zopiclone; oral

1.3

20.6

1715

13902

B02.9

ICD-10 Finland

Zoster without complication

1.7

20.4

373

2233

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.6

20.4

120

472

I27.0

ICD-10 Finland

Primary pulmonary hypertension

7.8

20.4

A10AC01

ATC

insulin (human); parenteral

1.7

20.3

425

2638

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

20.3

1308

10194

XA421

NOMESCO Finland

Nocturnal polygraphy

6.1

20.3

B01AA03

ATC

warfarin; systemic

1.4

20.3

1279

9935

J01MA02

ATC

ciprofloxacin; systemic

1.3

20.3

2122

17759

H05AA02

ATC

teriparatide; parenteral

4.8

20.1

A10AB05

ATC

insulin aspart; parenteral

1.7

19.8

414

2569

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

35.9

19.8

WX872

NOMESCO Finland

Intensive care

1.8

19.8

308

1761

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

19.8

295

1665

L04AB06

ATC

golimumab; parenteral

4.9

19.6

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

19.6

129

536

WX002

NOMESCO Finland

Sedation and analgesia

1.4

19.5

1033

7789

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.8

19.3

287

1618

RS123, ,

NOMESCO Finland

15.6

19.2

NDG30

NOMESCO Finland

Fusion of wrist, total

4.9

19.2

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.3

18.9

136

588

R01AD12

ATC

fluticasone furoate; nasal

1.4

18.8

1171

9065

L04AA17

ATC

[U] adalimumab

6.6

18.7

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

5.9

18.7

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.1

18.7

261

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.3

18.6

139

611

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

18.5

153

701

M25.5

ICD-10 Finland

Pain in joint

1.3

18.4

1363

10824

SPAT1263

SPAT

Sampling

1.3

18.4

2077

17490

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

15.1

18.4

R76.0

ICD-10 Finland

Raised antibody titre

6.9

18.2

R03AK11

ATC

formoterol and fluticasone; inhalant

2.4

18.2

130

560

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

3.8

18.2

142

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

18.2

317

1874

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

18.0

289

1669

120

Kela drug reimbursment

Hypogammaglobulinaemia

15.3

17.9

L01CB

ATC

Podophyllotoxin derivatives

6.7

17.8

132

Kela drug reimbursment

Sarcoidosis

4.0

17.8

122

R74

ICPC

Upper respiratory infection acute

1.4

17.6

1045

8013

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

17.6

171

836

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

17.5

536

3637

R03AC03

ATC

terbutaline; inhalant

1.5

17.5

626

4388

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

17.4

731

5283

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

7.4

17.4

M05BA06

ATC

ibandronic acid; systemic

2.4

17.3

117

492

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

17.3

586

4061

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.0

17.1

248

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

17.1

413

2657

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

6.6

17.0

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

50.2

17.0

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

6.9

17.0

1240

FHL

Bronchoscopy

3.0

16.9

255

R01AD08

ATC

fluticasone; nasal

1.3

16.8

1187

9342

J02AC01

ATC

fluconazole; systemic

1.3

16.8

1516

12357

A28

ICPC

Limited function/disability NOS

1.4

16.7

1058

8191

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

16.7

279

1630

WX723

NOMESCO Finland

CPAP therapy

2.0

16.7

176

887

C03DA01

ATC

spironolactone; oral

1.4

16.6

687

4947

ZXA05

NOMESCO Finland

Left side

1.3

16.5

1319

10564

WX882

NOMESCO Finland

High dependency care

2.1

16.5

161

788

291

Kela drug reimbursment

Tofacitinib

7.3

16.5

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

23.1

16.4

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

4.3

16.4

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.6

16.4

148

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

16.3

425

2781

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

12.1

16.3

1CX01, ,

NOMESCO Finland

12.1

16.3

H02AB09

ATC

hydrocortisone; systemic

2.3

16.2

122

538

N03AX12

ATC

[U] gabapentin; oral

1.4

16.2

792

5873

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

16.0

108

454

C09AA05

ATC

ramipril; oral

1.3

16.0

1492

12204

J46

ICD-10 Finland

Status asthmaticus

2.1

15.9

142

673

M10.9

ICD-10 Finland

Gout, unspecified

1.6

15.9

432

2856

J05AB01

ATC

aciclovir; systemic

1.4

15.8

983

7582

M33.1

ICD-10 Finland

Other dermatomyositis

14.5

15.8

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

14.5

15.8

WVA20

NOMESCO Finland

Medicine administration

2.2

15.8

138

648

C08CA05

ATC

nifedipine; systemic

1.6

15.8

358

2268

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

60.2

15.7

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

15.7

278

1650

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.8

15.6

258

1502

L04AB05

ATC

certolizumab pegol; parenteral

6.0

15.6

XF402

NOMESCO Finland

ECG with work load test

1.5

15.5

591

4187

XX1VW

NOMESCO Finland

Written report from radiologist

3.5

15.5

149

M01CB03

ATC

auranofin; oral

3.5

15.5

149

AK3

BLTX (both lung transplants)

160.4

15.5

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

15.5

842

6356

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.3

15.4

121

544

WX402

NOMESCO Finland

General anaesthesia

1.4

15.4

910

6962

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.5

15.4

145

XQ800

NOMESCO Finland

Prick test

1.8

15.3

253

1473

ZX114

NOMESCO Finland

Intramuscular

2.8

15.3

264

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.1

15.3

143

690

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

15.3

392

2557

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

15.2

573

4053

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

15.2

1464

12013

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

15.2

373

2409

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

15.1

490

3361

C10AA03

ATC

pravastatin; oral

1.5

15.1

429

2862

R4120

NOMESCO Finland

Occupational therapy

1.7

15.0

306

1887

ZXD05

NOMESCO Finland

Urgent procedure

1.3

14.9

1480

12181

N18.8

ICD-10 Finland

Other chronic renal failure

2.0

14.9

159

805

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

14.9

385

2515

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.9

14.8

107

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

14.8

1426

11691

J02AC03

ATC

voriconazole; systemic

5.9

14.8

H26.3

ICD-10 Finland

Drug-induced cataract

4.0

14.7

103

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

4.3

14.7

WX740

NOMESCO Finland

Nitrogen oxide therapy

13.2

14.7

M05BX04

ATC

denosumab; parenteral

1.6

14.6

328

2072

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

14.6

456

3105

E000001, ,

ATC

1.4

14.6

869

6651

Angiography of the heart and coronary arteries

1.5

14.5

418

2796

WPA11

NOMESCO Finland

Developing a plan for palliative care

6.3

14.5

R01AD58

ATC

fluticasone, combinations; nasal

1.4

14.5

819

6215

XF622

NOMESCO Finland

Measurement of minute volume of heart

4.9

14.5

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

14.4

203

1127

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

14.4

1490

12318

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

14.4

249

1469

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.1

14.4

192

J01DA01

ATC

[U] cefalexin

1.2

14.3

3006

26971

B01AC04

ATC

clopidogrel; oral

1.3

14.3

1018

8003

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

14.3

162

839

ZY010

NOMESCO Finland

Hospital outpatient

1.9

14.2

175

931

R03BB07

ATC

umeclidinium bromide; inhalant

3.1

14.2

183

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.4

14.2

153

L95

ICPC

Osteoporosis

1.9

14.2

189

1032

R2110

NOMESCO Finland

Giving the first information

1.7

14.2

269

1628

R03AC13

ATC

formoterol; inhalant

1.7

14.0

251

1496

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.5

14.0

347

D07AB08

ATC

desonide; topical

1.5

14.0

483

3358

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

13.9

840

6437

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

13.9

1024

8084

B37.0

ICD-10 Finland

Candidal stomatitis

3.0

13.9

196

J01XB01

ATC

colistin; inhalant, parenteral

30.1

13.9

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.9

13.8

172

920

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.7

13.8

113

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

3.7

13.8

113

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

4.7

13.7

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

6.2

13.7

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

13.7

411

2774

B01AB04

ATC

dalteparin; parenteral

1.7

13.7

270

1651

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

13.7

2130

18461

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

13.6

437

2994

NG1DA

NOMESCO Finland

X-ray of knees

2.3

13.5

433

M54.5

ICD-10 Finland

Low back pain

1.3

13.5

1534

12815

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

13.5

207

1181

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

13.5

275

1697

R03AC19

ATC

olodaterol

4.1

13.4

SPAT1255

SPAT

Intravenous administration of medicine

1.5

13.4

365

2412

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

13.4

338

2195

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.5

13.4

134

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

3.0

13.4

195

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

13.3

1685

14252

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.8

13.3

197

1112

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

4.9

13.3

XX7LW, ,

NOMESCO Finland

6.3

13.3

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.8

13.2

240

R03BB01

ATC

ipratropium bromide; inhalant

1.7

13.2

234

1390

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

13.1

1598

13449

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

13.1

555

4009

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

13.0

127

623

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.2

13.0

162

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

13.0

1001

7948

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

12.9

278

1738

C10AA01

ATC

simvastatin; oral

1.2

12.9

2545

22576

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

4.2

12.9

3AC01, ,

NOMESCO Finland

3.0

12.9

189

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

50.1

12.8

WX727

NOMESCO Finland

Estimation of exercise oxygen therapy

50.1

12.8

Z71.8

ICD-10 Finland

Other specified counselling

1.3

12.8

1288

10585

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

12.8

159

849

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

12.7

296

1886

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.7

12.7

110

B01AB05

ATC

enoxaparin; parenteral

1.3

12.7

1625

13744

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.5

12.7

321

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

70.0

12.6

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

6.0

12.6

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

12.6

1583

13362

TNG10

NOMESCO Finland

Puncture of knee

2.8

12.5

225

C02KX04

ATC

macitentan; oral

17.3

12.5

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

12.5

398

2721

L04AA37

ATC

[U] baricitinib

10.0

12.5

NDL52

NOMESCO Finland

Tenosynovectomy of hand

3.4

12.4

126

ZX197, ,

NOMESCO Finland

20.1

12.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.6

12.4

283

TK800

NOMESCO Finland

Hemodialysis

2.1

12.4

115

554

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

2.5

12.3

308

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

12.3

1970

17069

L04AA29

ATC

[U] tofacitinib

5.8

12.2

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

12.2

622

4634

A02BA03

ATC

famotidine; systemic

1.7

12.2

205

1201

A02BA02

ATC

ranitidine; systemic

1.3

12.2

1004

8037

SBA10

NOMESCO Finland

Measurement of salivary flow rate

2.9

12.1

201

J45

ICD-10 Finland

Asthma

1.5

12.1

414

2870

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.5

12.1

114

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.4

12.0

354

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

12.0

204

1199

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.5

12.0

282

293

Kela drug reimbursment

Baricitinib

10.0

12.0

3006

Kela drug reimbursment

Baricitinib

9.3

12.0

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

11.9

340

2273

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.0

11.8

129

660

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.7

11.8

S18

ICPC

Laceration/cut

1.2

11.8

2339

20696

J01GB01

ATC

tobramycin; inhalant, parenteral

14.7

11.8

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

3.4

11.8

121

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.2

11.7

101

473

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.3

11.7

131

D07AD01

ATC

clobetasol; topical

1.3

11.7

734

5651

R03AC12

ATC

salmeterol; inhalant

1.7

11.7

236

1454

N07BA03

ATC

varenicline; oral

1.8

11.6

160

884

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

65.1

11.6

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.3

11.5

399

WX720

NOMESCO Finland

Own respiration

1.7

11.5

221

1343

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

5.2

11.5

A46

ICD-10 Finland

Erysipelas

1.3

11.5

781

6084

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

4.3

11.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

11.5

757

5872

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

3.5

11.4

109

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

3.4

11.4

114

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

11.3

199

1181

M06

ICD-10 Finland

Other rheumatoid arthritis

3.3

11.3

124

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

11.8

11.3

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.3

11.3

377

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

11.3

393

2736

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

3.8

11.3

J99.1*M34.8

ICD-10 Finland

Respiratory disorders in systemic: sclerosis

35.1

11.3

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.2

11.2

135

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.9

11.2

139

744

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

11.2

479

3466

H03AA01

ATC

levothyroxine sodium; systemic

1.3

11.2

1004

8121

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

5.5

11.2

C10AA05

ATC

atorvastatin; oral

1.2

11.1

2324

20627

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

11.1

343

2330

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.1

11.1

RS221, ,

NOMESCO Finland

2.5

11.1

269

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

11.0

1958

17100

XJC00

NOMESCO Finland

Oesophageal manometry

4.3

11.0

R03BB06

ATC

glycopyrronium bromide; inhalant

3.8

11.0

E000002, ,

ATC

1.4

10.9

421

2987

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.1

10.9

467

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

3.3

10.9

117

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.3

10.9

326

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

10.9

211

1287

R04.0

ICD-10 Finland

Epistaxis

1.4

10.9

419

2974

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.9

10.8

164

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

10.8

470

3408

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.9

10.8

136

731

S22.2

ICD-10 Finland

Fracture of sternum

3.3

10.8

118

SPAT1260

SPAT

Consultation of another employee

1.3

10.8

843

6693

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

3.0

10.7

149

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

2.9

10.7

165

B01AF02

ATC

apixaban; oral

1.3

10.7

740

5774

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

10.7

178

1041

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

21.5

10.7

K02.1

ICD-10 Finland

Caries of dentine

1.2

10.7

2438

21802

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

10.6

245

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

60.1

10.6

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

10.6

181

1067

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

10.5

1266

10596

J96.9

ICD-10 Finland

Respiratory failure, unspecified

2.9

10.5

167

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

10.0

10.5

D07XC01

ATC

betamethasone; topical

1.4

10.5

571

4301

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

+∞

10.4

304

Kela drug reimbursment

Dornase alfa

+∞

10.4

R24

ICPC

Haemoptysis

2.9

10.4

168

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

10.4

2776

25165

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.6

10.4

239

1521

A07EC02

ATC

mesalazine; oral, rectal

1.6

10.4

212

1310

6BA02, ,

NOMESCO Finland

5.4

10.4

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

10.3

2372

21196

R60.0

ICD-10 Finland

Localized oedema

1.3

10.3

629

4818

A04

ICPC

Weakness/tiredness general

1.3

10.3

677

5243

WPB10

NOMESCO Finland

Making a convalescent care decision

3.9

10.3

NDG74

NOMESCO Finland

Fusion of first IP joint

4.5

10.2

RK120, ,

NOMESCO Finland

4.5

10.2

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

3.7

10.2

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

10.2

146

818

R04

ICPC

Breathing problem other

1.7

10.2

167

974

J94.8

ICD-10 Finland

Other specified pleural conditions

2.0

10.1

488

ZX100

NOMESCO Finland

Oral

2.2

10.1

363

L28

ICPC

Limited function/disability (L)

1.3

10.1

957

7782

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

10.1

137

755

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.8

10.1

153

872

M54

ICD-10 Finland

Dorsalgia

1.4

10.1

452

3297

A01AB04

ATC

amphotericin B; local oral

1.6

10.0

230

1463

L03

ICPC

Low back symptom/complaint

1.3

10.0

1153

9596

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.4

10.0

104

B34.9

ICD-10 Finland

Viral infection, unspecified

2.0

9.9

478

XF404

NOMESCO Finland

Ambulatory ECG

1.4

9.9

457

3347

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.8

9.9

133

731

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.8

9.8

140

783

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

3.9

9.8

R53

ICD-10 Finland

Malaise and fatigue

1.3

9.8

1086

8993

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.3

9.8

304

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

9.8

315

2159

B07.9

ICD-10 Finland

Verruca simplex

1.8

9.8

131

720

M79.6

ICD-10 Finland

Pain in limb

1.2

9.8

1866

16365

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.2

9.7

343

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

9.5

9.7

D11

ICPC

Diarrhoea

1.4

9.7

405

2915

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

9.7

193

1185

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

9.7

408

2941

-1, ,

NOMESCO Finland

1.2

9.7

1275

10761

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.9

9.7

111

579

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

9.7

104

531

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.2

9.7

1342

11395

S29

ICPC

Skin symptom/complaint other

1.3

9.6

889

7203

NDF10

NOMESCO Finland

Synovectomy of wrist

5.3

9.6

XX4AW, ,

NOMESCO Finland

11.4

9.5

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

4.4

9.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

9.4

177

1071

RS230, ,

NOMESCO Finland

3.4

9.4

J93.9

ICD-10 Finland

Pneumothorax, unspecified

3.3

9.4

108

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.6

9.4

195

2770A

ICD-9 Finland

Other and unspecified disorders of metabolism, Cystic fibrosis

+∞

9.4

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.5

9.4

300

2055

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.7

9.3

170

1021

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.0

9.3

483

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

9.3

680

5343

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

9.3

374

2675

I50.1

ICD-10 Finland

Left ventricular failure

1.5

9.3

287

1951

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

2.9

9.3

151

RK250, ,

NOMESCO Finland

3.2

9.3

109

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.5

9.3

214

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.2

9.3

325

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.0

9.2

130

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.1

9.2

384

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.1

9.2

371

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

9.2

1474

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

9.2

162

2635

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.0

9.2

438

N06DX01

ATC

memantine; oral

0.7

9.1

227

3417

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

9.1

327

2291

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.6

9.1

226

1466

M05BB04

ATC

risedronic acid, calcium and colecalciferol, sequential; oral

5.0

9.1

Z31.5

ICD-10 Finland

Genetic counselling

1.7

9.1

152

893

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.2

9.1

354

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

4.8

9.0

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

9.0

3100

28582

RK220, ,

NOMESCO Finland

4.0

9.0

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

4.0

9.0

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

36.7

9.0

J98.2

ICD-10 Finland

Interstitial emphysema

10.0

9.0

207

Kela drug reimbursment

Chronic arrhythmias

1.3

9.0

941

7735

R06AX27

ATC

desloratadine; oral

1.3

9.0

973

8034

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

8.9

531

4051

N17.8

ICD-10 Finland

Other acute renal failure

2.2

8.9

330

C02KX01

ATC

bosentan; oral

18.6

8.9

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

18.6

8.9

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.1

8.9

117

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

8.9

584

4521

J01FA01

ATC

erythromycin; systemic

1.4

8.9

460

3436

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.9

8.9

116

633

D05AX52

ATC

calcipotriol, combinations; topical

1.6

8.8

227

1485

UGC02

NOMESCO Finland

Rigid bronchoscopy

4.7

8.8

T90

ICPC

Diabetes non-insulin dependent

1.2

8.8

1263

10746

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

8.8

125

700

I50

ICD-10 Finland

Heart failure

1.6

8.8

185

1155

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.3

8.7

535

4099

GD1AA, ,

SPAT

1.4

8.7

334

2368

WPA13

NOMESCO Finland

Palliative consultation

3.7

8.7

C08CA02

ATC

felodipine; oral

1.3

8.7

525

4014

M01AH02

ATC

rofecoxib; oral

1.3

8.7

616

4819

M32

ICD-10 Finland

Systemic lupus erythematosus

14.0

8.7

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.5

8.6

270

1841

A11

ICPC

Chest pain NOS

1.4

8.6

396

2899

M48.0

ICD-10 Finland

Spinal stenosis

1.3

8.6

657

5190

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

8.6

445

3322

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

4.4

8.6

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

3.2

8.6

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.5

8.6

287

1984

A41.9

ICD-10 Finland

Sepsis, unspecified

1.6

8.6

187

1177

B59

ICD-10 Finland

Pneumocystosis

8.2

8.6

4040, ,

NOMESCO Finland

11.6

8.6

SPAT1059

SPAT

Spirometry at the office

1.5

8.5

241

1609

R52.0

ICD-10 Finland

Acute pain

1.8

8.5

126

714

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.0

8.5

451

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.9

8.5

103

549

R07.3

ICD-10 Finland

Other chest pain

1.4

8.5

454

3408

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

8.5

385

2814

Z94.3

ICD-10 Finland

Heart and lungs transplant status

27.5

8.5

E000003, ,

ATC

1.6

8.5

171

1056

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.5

3035

28016

3A064, ,

NOMESCO Finland

3.3

8.5

D02AE01

ATC

carbamide; topical

1.5

8.4

271

1858

XQ848

NOMESCO Finland

Dermatological photography

1.7

8.4

143

843

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.4

8.4

224

M01AB05

ATC

diclofenac; systemic, rectal

1.2

8.4

3069

28363

E84.8

ICD-10 Finland

Cystic fibrosis with other manifestations

90.2

8.4

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

8.4

1804

15944

N19

ICD-10 Finland

Unspecified kidney failure

1.6

8.3

201

1296

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.3

8.3

250

5168X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies

+∞

8.3

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

8.3

674

5368

RT271, ,

NOMESCO Finland

8.5

8.3

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

8.5

8.3

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

8.3

410

3041

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

2.6

8.3

167

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

9.4

8.3

M02AA07

ATC

piroxicam; topical

1.2

8.3

1752

15459

M01AE02

ATC

naproxen; oral, rectal

1.2

8.2

2457

22317

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.1

8.2

107

P01AB01

ATC

metronidazole; oral, rectal

1.2

8.2

1675

14724

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.6

8.2

183

1159

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.1

8.2

329

N06DA02

ATC

donepezil; oral

0.6

8.2

162

2560

C01AA05

ATC

digoxin; systemic

1.3

8.1

472

3587

I26

ICD-10 Finland

Pulmonary embolism

2.5

8.1

192

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

4.5

8.1

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

8.1

602

Kela drug reimbursment

Children's severe malnutrition

17.2

8.1

K51.8

ICD-10 Finland

Other ulcerative colitis

2.3

8.1

254

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

8.0

1794

15894

FXE00

NOMESCO Finland

Use of ECLA

22.0

8.0

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

22.0

8.0

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.5

8.0

214

1413

NXL00

NOMESCO Finland

Biopsy of muscle

3.6

8.0

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.3

8.0

554

4321

M60.9

ICD-10 Finland

Myositis, unspecified

3.1

8.0

104

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.4

8.0

206

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

1.8

8.0

106

583

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

7.2

7.9

G53.0

ICD-10 Finland

Postzoster neuralgia

2.7

7.9

159

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.2

7.9

307

SPAT1310

SPAT

Counselling related to known health issue

1.2

7.9

1455

12662

ZY000

NOMESCO Finland

Hospital inpatient

2.6

7.9

171

M01AX17

ATC

nimesulide; oral

1.2

7.9

1150

9788

DHA10

NOMESCO Finland

Biopsy of cavity of nose

2.7

7.9

154

WX204

NOMESCO Finland

Axillary plexus blockaced

1.7

7.9

136

807

L04AA11

ATC

[U] etanercept

3.9

7.9

M01CC01

ATC

penicillamine; oral

6.6

7.9

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.3

7.9

238

L01BB01, ,

ATC

6.1

7.8

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

6.1

7.8

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

7.8

342

N06DA03

ATC

rivastigmine; oral, transdermal

0.5

7.8

1690

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

7.8

1238

10623

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

7.8

191

1237

R06AX22

ATC

ebastine; oral

1.3

7.8

595

4701

SBA00

NOMESCO Finland

Microbiological examinations

1.8

7.8

106

587

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.7

7.8

123

712

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

7.8

809

6639

D05BB02

ATC

acitretin; oral

1.8

7.8

102

559

RS220, ,

NOMESCO Finland

2.3

7.7

246

WX730

NOMESCO Finland

Conventional respirator

2.0

7.7

384

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

45.0

7.7

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

15.0

7.7

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.7

1135

9668

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

7.7

269

1877

D72.1

ICD-10 Finland

Eosinophilia

3.5

7.7

L02

ICPC

Back symptom/complaint

1.4

7.7

348

2544

Coronary artery bypass surgery

1.7

7.7

141

851

M10

ICD-10 Finland

Gout

1.5

7.6

237

1615

B01AC06

ATC

acetylsalicylic acid; oral

1.5

7.6

198

1299

GDB10

NOMESCO Finland

Wedge resection of lung

4.5

7.6

R11

ICD-10 Finland

Nausea and vomiting

1.4

7.6

354

2598

S97

ICPC

Chronic ulcer skin

1.4

7.6

316

2275

ZX121

NOMESCO Finland

Central venous catheter

3.7

7.6

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

7.6

532

4155

N06AX11

ATC

mirtazapine; oral

1.2

7.6

1483

12970

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

7.6

1435

12514

WX213

NOMESCO Finland

Lower leg blockade

2.5

7.6

175

D68.8

ICD-10 Finland

Other specified coagulation defects

2.5

7.6

181

L17

ICPC

Foot/toe symptom/complaint

1.2

7.5

1317

11401

M05.3

ICD-10 Finland

Rheumatoid arthritis with involvement of other organs and systems

8.8

7.5

J43.1

ICD-10 Finland

Panlobular emphysema

8.8

7.5

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

7.5

1782

15850

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

7.5

371

2753

L03AA02

ATC

filgrastim; parenteral

1.7

7.5

131

781

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

7.5

417

3153

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.1

7.4

342

NDG76

NOMESCO Finland

Fusion of DIP joint

2.6

7.4

153

R4130

NOMESCO Finland

Speech therapy

1.7

7.4

119

692

XV5WT, ,

NOMESCO Finland

80.2

7.4

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.0

7.4

377

R03BB05

ATC

aclidinium bromide; inhalant

3.4

7.4

R03DA04

ATC

theophylline; systemic, rectal

1.4

7.4

273

1926

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

1.9

7.4

489

L04AC14

ATC

sarilumab; systemic

13.4

7.4

ZX140

NOMESCO Finland

Intra articular

2.6

7.3

154

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

4.0

7.3

WX780

NOMESCO Finland

Remote monitoring CPAP

1.6

7.3

157

986

SFA10

NOMESCO Finland

One-surface restoration

1.2

7.3

2272

20639

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.9

7.3

427

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

2.7

7.3

143

UGC08

NOMESCO Finland

Rigid bronchoscopy with biopsy of lung

+∞

7.3

6BB16, ,

NOMESCO Finland

+∞

7.3

A02BA04

ATC

nizatidine; systemic

1.4

7.3

370

2756

I20.91

ICD-10 Finland

Angina pectoris, unspecified

2.0

7.3

400

RT272, ,

NOMESCO Finland

4.1

7.3

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.4

7.3

310

2244

M10.0

ICD-10 Finland

Idiopathic gout

1.5

7.3

190

1250

EB1WA, ,

NOMESCO Finland

2.9

7.3

110

K08.3

ICD-10 Finland

Retained dental root

1.4

7.2

342

2518

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

1.8

7.2

550

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

7.2

868

7236

S22.3

ICD-10 Finland

Fracture of rib

1.4

7.2

328

2400

L57.0

ICD-10 Finland

Actinic keratosis

1.3

7.2

591

4713

M13.0

ICD-10 Finland

Polyarthritis, unspecified

2.3

7.2

235

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

7.2

157

991

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

2.1

7.2

307

R13

ICD-10 Finland

Dysphagia

1.4

7.2

331

2429

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.4

7.2

336

2472

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.5

7.1

244

1696

J98.6

ICD-10 Finland

Disorders of diaphragm

3.1

7.1

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

7.1

167

1072

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.7

7.1

113

656

XG430

NOMESCO Finland

Spiroegometry

12.0

7.1

7102A

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]

12.0

7.1

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.5

7.1

175

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

7.0

964

8145

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.8

7.0

100

563

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.0

7.0

344

WW409

NOMESCO Finland

Other aferesis

4.4

6.9

M05BX03

ATC

strontium ranelate; oral

2.8

6.9

124

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

1.8

6.9

550

SPAT1254

SPAT

Administration of medicine

1.3

6.9

714

5852

UDM02

NOMESCO Finland

Sinoscopy

1.9

6.9

464

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

1.8

6.9

544

RK310, ,

NOMESCO Finland

7.5

6.9

G04BE08

ATC

tadalafil; oral

4.0

6.9

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

6.9

137

846

Z50.1

ICD-10 Finland

Other physical therapy

1.5

6.9

236

1643

A04AA01

ATC

ondansetron; systemic, rectal

1.4

6.9

330

2438

AA1AD

NOMESCO Finland

CT of head and brain

1.2

6.8

1436

12619

SPAT1097

SPAT

Recording of ECG

1.2

6.8

739

6088

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

3.4

6.8

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

2.5

6.8

172

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.7

6.8

116

687

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.8

1753

15666

A91

ICPC

Abnormal result investigation NOS

1.5

6.8

213

1456

L95.8

ICD-10 Finland

Other vasculitis limited to skin

3.8

6.8

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.7

6.8

110

643

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

9.3

6.8

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.4

6.7

179

K76.9

ICD-10 Finland

Liver disease, unspecified

2.1

6.7

281

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

16.7

6.7

R79

ICPC

Chronic bronchitis

3.9

6.7

R06AE09

ATC

levocetirizine; oral

1.3

6.7

474

3709

M03BX02

ATC

tizanidine; oral

1.2

6.7

2615

24119

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

1.8

6.7

542

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.7

1781

15957

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.6

6.7

163

1057

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

6.7

551

4398

P70

ICPC

Dementia

0.4

6.6

834

N30.2

ICD-10 Finland

Other chronic cystitis

2.4

6.6

187

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

3.0

6.6

Z01.2

ICD-10 Finland

Dental examination

1.2

6.6

1762

15785

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

5.9

6.6

XG422

NOMESCO Finland

Time-volume spirometry with bronchodialtation

5.5

6.6

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.7

6.6

124

756

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

1.8

6.6

538

8041/3-C34.3

ICD-O-3

Small cell carcinoma, NOS, of lower lobe, lung

8.7

6.5

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.5

6.5

1350

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

6.5

670

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

10.0

6.5

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.6

6.5

125

765

M31.7

ICD-10 Finland

Microscopic polyangiitis

6.8

6.5

K29.7

ICD-10 Finland

Gastritis, unspecified

1.6

6.5

161

1049

R5110, ,

SPAT

1.4

6.5

310

2290

WNF00

NOMESCO Finland

Infection source and contact determination

3.1

6.5

B01AB10

ATC

tinzaparin; parenteral

1.3

6.4

435

3381

J99.1*M33.9

ICD-10 Finland

Respiratory disorders in dermatopolymyositis

69.9

6.4

51701

ICD-8 Finland

Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)

69.9

6.4

D01

ICPC

Abdominal pain/cramps general

1.3

6.4

413

3190

R63.4

ICD-10 Finland

Abnormal weight loss

1.5

6.4

185

1245

S01BA01

ATC

dexamethasone; ophthalmic

1.6

6.4

143

909

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.4

6.4

320

2381

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.6

6.4

156

1013

R78

ICPC

Acute bronchitis/bronchiolitis

1.8

6.4

521

S70

ICPC

Herpes zoster

1.6

6.4

126

778

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

2.9

6.3

102

H01

ICPC

Ear pain/earache

1.3

6.3

378

2887

J98.1

ICD-10 Finland

Pulmonary collapse

2.5

6.3

142

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

6.3

696

5744

OAB50, ,

SPAT

1.4

6.3

242

1720

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

1.9

6.3

385

XX9XW, ,

NOMESCO Finland

2.8

6.3

108

F03

ICD-10 Finland

Unspecified dementia

0.6

6.3

1626

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.7

6.3

100

582

K51.5

ICD-10 Finland

Left sided colitis

1.8

6.3

508

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

5.9

6.3

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

6.3

300

2215

RK520, ,

NOMESCO Finland

3.2

6.3

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

9.2

6.3

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.5

6.3

I20.0

ICD-10 Finland

Unstable angina

2.2

6.3

243

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

3.2

6.3

J67.8

ICD-10 Finland

Hypersensitivity pneumonitis due to other organic dusts

18.0

6.3

XG413

NOMESCO Finland

Spirometry with oscillometry

18.0

6.3

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

3.8

6.2

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.7

6.2

109

651

R03AC18

ATC

indacaterol; inhalant

2.3

6.2

192

I20.09

ICD-10 Finland

Unstable angina

1.4

6.2

310

2304

M01AB55

ATC

diclofenac, combinations; oral

1.4

6.2

310

2304

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.3

6.2

186

J92

ICD-10 Finland

Pleural plaque

7.0

6.2

R01

ICPC

Pain respiratory system

2.0

6.2

311

TEA00

NOMESCO Finland

Biopsy of lip

2.2

6.2

218

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1.7

6.2

104

615

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

2.7

6.2

115

E66.8

ICD-10 Finland

Other obesity

1.5

6.2

156

1021

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

4.0

6.2

Z94.4

ICD-10 Finland

Liver transplant status

4.0

6.2

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

3.1

6.2

R07.1

ICD-10 Finland

Chest pain on breathing

2.0

6.1

292

J86.9

ICD-10 Finland

Pyothorax without fistula

2.2

6.1

213

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

6.1

269

1961

S20.2

ICD-10 Finland

Contusion of thorax

1.4

6.1

211

1474

A07EA06

ATC

budesonide; oral, local oral

1.6

6.1

125

780

ECB20

NOMESCO Finland

Oral alveoplasty

2.1

6.1

240

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

6.0

781

6555

51709

ICD-8 Finland

Other chronic interstitial pneumonia, Unspecified

6.7

6.0

E000007, ,

ATC

1.5

6.0

184

1254

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42529582) MDA5 Ab [Presence] in Serum by Line blot

223

26.65

323.31

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

223

26.65

323.31

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

223

26.65

323.31

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

223

26.65

323.31

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

650

932

7.75

307.65

1.3

1.2

13.35

6.15

u/ml

1.37

137

146

(3037692) Legionella sp identified in Specimen by Organism specific culture

310

138

23.71

307.65

2.0

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2064

6682

4.29

307.65

1.4

1.3

61.15

36.14

iu/ml

5.17

713

2064

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

424

491

9.26

307.65

2.7

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1394

1958

9.13

307.65

1.6

20.05

16.19

u/ml

0.20

(3023419) Bacteria identified in Sputum by Culture

665

743

10.01

307.65

2.6

2.4

—

(3037522) Nuclear Ab [Titer] in Serum

2299

5184

6.79

307.65

1.5

1.3

574.14

509.47

titre

0.83

693

1090

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

821

1810

5.14

307.65

1.8

38.98

38.34

u/l

0.33

746

1543

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

597

768

8.57

307.65

1.3

1.2

17.86

2.28

u/ml

1.67

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1688

6074

3.54

307.65

2.5

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

909

1399

7.55

307.65

1.3

1.2

1.95

0.99

u/ml

0.86

131

(3002030) Lymphocytes/100 leukocytes in Blood

4069

22036

4.03

307.65

12.6

6.0

24.81

26.44

17.32

3988

20438

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

825

1268

7.45

307.65

1.6

1.4

12.07

17.20

iu/ml

0.45

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

643

1178

6.03

307.65

1.8

1.4

1.19

1.16

g/l

1.48

624

1109

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

567

665

9.37

307.65

2.4

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

544

656

9.07

307.65

1.1

—

(3022096) Basophils/100 leukocytes in Blood

4014

20892

4.19

307.65

12.3

5.8

0.63

0.66

3.18

3936

19295

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

424

491

9.26

307.65

2.7

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1049

1106

11.42

307.65

1.9

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

613

915

7.39

307.65

1.3

1.2

197.39

140.00

titre

0.19

(3013650) Neutrophils [#/volume] in Blood by Automated count

4394

26681

3.92

307.65

15.4

8.8

4.70

4.26

e9/l

26.40

4055

23082

(3006504) Eosinophils/100 leukocytes in Blood

4054

21526

4.13

307.65

12.4

5.8

2.72

2.87

4.24

3974

19903

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

555

738

8.23

307.65

2.5

1.5

—

(3006315) Basophils [#/volume] in Blood

4291

22929

4.63

307.65

11.7

5.5

0.04

e9/l

4.83

3911

19527

(40760892) CBC W Ordered Manual Differential panel - Blood

4161

21443

4.58

307.65

13.4

6.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

639

1138

6.20

307.65

1.8

1.4

0.23

0.24

g/l

2.30

618

1075

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1926

6287

4.13

307.65

1.3

1.2

27.33

13.11

u/ml

2.37

559

2283

(3001604) Monocytes [#/volume] in Blood

4286

22851

4.64

307.65

11.7

5.5

0.67

0.62

e9/l

19.97

3905

19455

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2114

8810

3.24

307.65

2.8

1.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

731

286

29.21

307.65

2.1

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

810

786

11.86

307.65

2.0

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

647

920

7.81

307.65

1.3

1.2

8.01

2.91

u/ml

0.82

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

853

1145

8.60

307.65

2.3

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

524

544

10.52

307.65

2.6

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

785

1133

7.89

307.65

1.9

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1005

1529

7.78

307.65

1.8

1.6

272.88

231.73

titre

0.21

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

664

991

7.46

307.65

1.3

1.2

39.56

44.34

u/ml

0.13

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1267

1833

8.62

307.65

3.1

2.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1689

6050

3.56

307.65

2.6

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

848

1095

8.94

307.65

2.4

1.5

—

(4200892) Spirometry reversibility

1137

3261

4.11

307.65

2.0

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

665

1199

6.15

307.65

2.4

2.2

129.29

127.37

g/l

0.65

275

910

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

555

738

8.23

307.65

2.5

1.5

—

(3019060) Gas panel - Arterial blood

1220

3683

3.95

307.65

4.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

698

638

12.34

307.65

2.0

1.4

—

(3013115) Eosinophils [#/volume] in Blood

4353

23672

4.67

307.65

12.4

5.7

0.21

0.20

e9/l

2.92

4008

20412

(3000492) Spirometry study

1203

3731

3.83

307.65

2.8

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

738

778

10.76

307.65

1.2

51.31

0.62

u/ml

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

578

701

9.07

307.65

1.5

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

565

628

9.89

307.65

1.8

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

670

846

8.85

307.65

2.4

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1281

3248

4.81

307.65

4.0

2.6

10.40

10.48

g/l

0.21

1225

2940

(3018010) Neutrophils/100 leukocytes in Blood

4032

21700

4.00

307.65

12.0

5.7

60.24

58.21

21.38

3951

20114

(3019198) Lymphocytes [#/volume] in Blood

4301

23389

4.52

307.65

11.9

5.6

1.91

1.89

e9/l

0.18

3960

20332

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

490

156

34.30

307.65

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1007

2569

4.55

307.65

2.2

1.9

1.10

1.40

g/l

4.64

937

2293

(3019069) Monocytes/100 leukocytes in Blood

4061

21641

4.12

307.65

12.9

6.1

8.88

8.89

0.03

3978

20035

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

553

848

7.12

307.65

12.1

4.5

1533.19

2293.74

iu/ml

0.14

132

117

(3042631) Mycobacterium sp identified in Specimen

568

727

8.58

307.65

3.0

2.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

601

712

9.33

307.65

1.8

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1602

6303

3.15

298.53

8.9

6.9

5.03

5.07

kpa

0.95

1545

5985

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

404

516

8.36

298.26

3.4

3.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1601

6301

3.15

298.14

8.9

6.9

10.26

12.10

kpa

53.09

1547

5979

(3005322) IgE [Units/volume] in Serum or Plasma

858

2241

4.34

297.50

1.6

1.2

247.93

233.97

u/ml

0.16

802

2030

(3003396) Base excess in Arterial blood by calculation

1583

6284

3.11

289.35

8.9

6.9

1.38

1.09

mmol/l

1.89

1338

4907

(3017181) Myelocytes/100 leukocytes in Blood

1200

4061

3.48

285.49

6.0

3.9

0.87

0.99

1.01

520

1501

(3002179) Metamyelocytes/100 leukocytes in Blood

1113

3677

3.52

274.11

5.8

3.8

0.60

0.74

1.25

461

1289

(3039162) Centromere protein B Ab [Units/volume] in Serum

350

433

8.55

264.89

1.3

1.2

59.92

48.80

u/ml

0.25

(3000494) Fungus identified in Specimen by Culture

1374

5319

3.09

259.16

2.3

1.4

—

(3023368) Bacteria identified in Blood by Culture

2717

14949

2.58

257.98

6.0

4.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

304

328

9.74

255.90

1.9

1.4

—

(3025159) Blasts/100 leukocytes in Blood

1073

3608

3.44

255.72

6.0

4.0

0.25

0.28

0.06

386

1075

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

546

1112

5.33

255.38

1.7

1.9

10.89

12.54

mg/l

1.91

512

1013

(3021440) Promyelocytes/100 leukocytes in Blood

1109

3857

3.33

249.90

6.1

3.9

0.08

0.12

1.44

425

1304

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

282

285

10.36

248.93

2.0

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

281

284

10.36

248.03

2.0

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

200

115

17.99

246.38

1.3

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

418

686

6.50

245.32

1.4

1.2

61.77

44.74

u/ml

0.94

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3864

25467

2.64

244.90

9.9

6.2

11.27

12.30

umol/l

5.54

3760

24167

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

141

38.03

228.79

3.1

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1223

4741

3.02

227.18

1.5

1.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

4613

34000

2.95

220.21

9.6

4.1

18.22

13.85

mm/h

52.94

4504

31031

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2815

16594

2.39

218.73

4.1

3.2

1671.25

1735.89

ng/l

0.28

2552

14418

(3021589) Normoblasts [#/volume] in Blood

3211

20059

2.39

218.15

18.9

10.1

0.00

e9/l

0.81

2737

16278

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

309

416

7.80

217.40

2.1

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

293

373

8.23

216.16

1.4

1.3

7.64

6.73

g/l

1.88

203

256

(3028192) IgG subclass 2 [Mass/volume] in Serum

292

373

8.20

214.80

1.4

1.3

3.04

2.92

g/l

0.41

204

259

(3024139) IgG subclass 3 [Mass/volume] in Serum

292

373

8.20

214.80

1.4

1.3

0.51

0.41

g/l

2.63

203

259

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3531

23093

2.41

214.51

9.4

6.2

1.20

1.21

mmol/l

4.17

3344

20890

(3004616) Nuclear Ab [Presence] in Serum

328

480

7.19

214.23

1.3

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

384

664

6.13

213.45

5.2

2.4

727.69

2754.80

u/ml

1.03

(3018418) pH of Serum or Plasma

2609

15000

2.37

213.08

5.5

4.1

7.40

0.95

611

2833

(4062490) Immunoglobulin typing, IgG

291

377

8.08

211.51

1.4

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

367

625

6.21

207.10

1.7

1.6

0.89

g/l

0.01

267

473

(3016502) Oxygen saturation in Arterial blood

1340

5710

2.77

206.77

9.7

7.2

93.89

95.49

14.37

1298

5484

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

847

2846

3.32

198.93

10.7

8.9

24.69

24.28

mmol/l

2.83

818

2736

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3718

25453

2.35

194.46

10.3

6.9

1.21

mmol/l

1.68

3156

21532

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

302

458

6.91

190.62

2.0

1.6

—

(3042936) Bacteria identified in Isolate by Culture

1509

7111

2.53

187.54

2.5

2.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

247

304

8.45

187.17

1.2

1.1

28.50

3.19

u/ml

1.42

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

308

487

6.63

186.81

2.0

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

252

322

8.15

185.11

1.2

1.1

56.54

38.41

u/ml

0.49

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

250

321

8.10

182.88

1.2

1.1

79.40

78.56

u/ml

—

(3038026) Centromere Ab [Units/volume] in Serum

253

332

7.93

181.69

1.2

1.1

28.81

75.98

u/ml

1.02

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

226

272

8.61

174.31

4.0

3.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1521

7440

2.43

172.28

1.9

1.5

2.85

2.63

g/l

2.77

1107

4289

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

397

869

4.84

169.32

4.6

3.7

59.50

58.16

1.01

397

869

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4671

36646

2.59

160.44

14.4

7.7

78.41

80.60

u/l

2.58

4581

34340

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

166

150

11.37

157.87

2.1

1.9

59579.04

24049.19

u/ml

0.25

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1794

9820

2.21

152.95

2.4

1.7

1.52

1.43

mg/l

0.37

1496

7616

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

680

2340

3.17

151.49

2.4

1.9

1.88

2.59

ug/l

0.51

622

2027

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

348

760

4.81

148.55

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2328

14226

2.08

147.95

5.3

3.2

34.51

36.90

u/l

0.59

2231

13396

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

346

759

4.79

146.88

1.3

1.4

39.16

14.09

u/ml

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

197

254

8.00

143.41

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

197

254

8.00

143.41

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

197

255

7.97

142.93

1.3

1.1

—

(36304419) Bacteria [Presence] in Urine

2238

13625

2.06

142.25

4.7

3.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

197

257

7.91

141.98

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

197

257

7.91

141.98

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

197

257

7.91

141.98

1.3

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

316

661

5.00

141.90

1.3

1.4

134.80

122.28

u/ml

0.24

140

(3042733) HLA Ab [Presence] in Serum

130

14.13

141.72

4.2

4.9

—

(3002582) Erythrocytes [#/volume] in Urine

2461

15538

2.04

141.15

4.9

3.5

94.54

100.74

e6/l

0.04

1992

12171

(3021879) Hepatitis B virus core Ab [Presence] in Serum

674

2428

3.02

138.15

1.3

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

441

1220

3.84

137.72

1.6

59.52

5.67

iu/ml

0.90

103

282

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

861

3546

2.69

137.21

6.0

3.8

5.15

5.16

kpa

0.05

825

3348

(40758558) Short blood count panel - Blood

1997

11782

2.08

137.10

10.9

6.6

—

(3030467) Casts [#/volume] in Urine by Automated count

2289

14214

2.03

136.22

4.7

3.3

0.39

0.48

e6/l

1.01

1817

11046

(3009343) pH of Capillary blood

850

3498

2.68

135.56

5.9

3.8

7.43

7.41

3.58

154

438

(3018095) Leukocytes [#/volume] in Urine

2676

17578

1.99

135.48

5.9

3.9

82.42

108.07

e6/l

0.65

2061

12928

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

830

3380

2.71

135.13

5.7

3.8

2.28

1.85

mmol/l

2.77

656

2476

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1111

5199

2.42

135.08

11.0

7.5

124.03

120.24

g/l

6.91

1084

5055

(3017143) Hepatitis C virus Ab [Presence] in Serum

901

3830

2.61

134.52

1.5

—

(1616796) Gas panel - Central venous blood

428

1210

3.75

129.35

5.3

3.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3131

21947

1.96

128.67

6.3

4.9

33.52

34.76

g/l

27.42

2934

20261

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

771

3097

2.73

128.58

11.7

7.1

25.07

24.81

mmol/l

0.94

763

3072

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

935

4166

2.49

125.85

1.5

—

(3011412) CD3 cells [#/volume] in Blood

231

410

5.83

124.33

2.2

2.0

0.99

1.14

e9/l

1.60

214

364

(3036481) Cortisol [Moles/volume] in Serum or Plasma

900

3975

2.50

123.26

2.1

2.2

344.89

374.09

nmol/l

3.10

848

3628

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

230

415

5.74

121.65

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

230

415

5.74

121.65

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

230

415

5.74

121.65

1.6

—

(3024932) HLA-DR beta [Type]

119

12.51

120.78

1.0

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

469

1474

3.38

120.38

4.8

3.0

25.42

24.86

mmol/l

1.97

454

1444

(3024471) HLA-A [Type]

120

100

12.24

120.13

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

216

372

6.00

119.93

1.9

1.2

20.33

25.87

iu/ml

0.46

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

144

158

9.33

119.20

3.5

1.7

42.43

59.48

ug/l

1.47

144

151

(40767503) Oxygen content in Capillary blood by calculation

405

1167

3.66

118.81

3.5

2.5

15.90

15.96

0.09

231

625

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1497

8322

2.09

117.37

6.5

3.1

0.81

mmol/l

0.49

1403

7727

(3022217) INR in Platelet poor plasma by Coagulation assay

3421

25132

1.92

117.35

18.9

18.7

1.29

1.36

inr

4.81

1140

7029

(1175426) CD3 cells/100 lymphocytes in Blood

195

311

6.46

116.91

2.1

2.0

72.06

70.71

0.44

190

289

(3000850) Epithelial cells [#/volume] in Urine

1837

11051

1.98

115.18

3.8

2.7

4.52

4.64

e6/l

0.13

1682

9915

(3001964) Herpes simplex virus Ag [Presence] in Specimen

127

123

10.54

115.09

3.0

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3810

29161

1.94

113.52

8.4

4.9

6.83

6.86

mmol/l

0.43

3678

27481

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

418

1271

3.47

112.87

3.3

2.4

3.82

3.59

g/l

2.21

410

1203

(3021901) Oxygen saturation in Capillary blood

376

1081

3.66

110.53

4.5

2.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

197

339

5.99

109.42

1.4

1.1

—

(3026782) Osmolality of Urine

1748

10490

1.97

109.25

4.0

3.0

531.68

547.22

mosm/kgh2o

2.73

1563

9005

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

183

297

6.33

107.82

2.2

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

146

186

8.03

107.25

1.4

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

419

1326

3.33

106.06

5.7

3.2

7.73

7.97

kpa

2.32

408

1295

(3008152) Bicarbonate [Moles/volume] in Arterial blood

792

3524

2.45

105.67

8.3

6.7

24.95

24.51

mmol/l

2.57

765

3351

(3020779) Urea [Moles/volume] in Serum or Plasma

1004

4988

2.23

103.58

11.5

6.8

10.60

10.90

mmol/l

0.65

962

4721

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1183

6330

2.10

100.70

4.7

4.1

267.65

245.94

u/l

4.24

1124

5960

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1003

5037

2.21

100.49

4.2

3.0

232.52

231.16

ng/l

0.03

942

4623

(3022948) Iron [Moles/volume] in Serum or Plasma

1437

8301

1.98

98.66

2.8

2.6

11.71

12.36

umol/l

2.98

1364

7676

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2672

18788

1.80

98.57

2.8

2.2

77.42

79.04

nmol/l

2.29

2469

16450

(3027315) Oxygen [Partial pressure] in Blood

383

1199

3.35

98.52

6.8

4.5

8.23

8.41

kpa

1.19

376

1173

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

195

369

5.44

97.87

1.4

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4061

32431

1.90

97.84

6.8

4.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1358

7720

2.00

97.45

2.8

2.6

2.25

2.27

g/l

0.71

1268

7105

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1303

7305

2.02

97.22

2.9

2.6

20.96

21.96

1.86

1110

6156

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

239

545

4.53

96.34

1.3

1.2

2.35

3.60

u/ml

0.74

162

(3012501) Base excess in Blood by calculation

378

1191

3.33

96.19

6.8

4.5

2.71

2.63

mmol/l

0.21

288

816

(3013290) Carbon dioxide [Partial pressure] in Blood

378

1192

3.33

96.05

6.8

4.5

5.00

4.99

kpa

0.08

371

1167

(3014576) Chloride [Moles/volume] in Serum or Plasma

1226

6777

2.03

94.87

11.4

6.7

103.96

104.41

mmol/l

2.68

1226

6771

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

258

637

4.20

93.82

1.2

344.05

295.57

u/ml

0.96

169

373

(3000991) Gas panel - Venous blood

905

4488

2.21

92.96

11.8

7.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

270

697

4.02

92.43

1.2

—

(3010421) pH of Blood

410

1392

3.10

92.05

6.7

4.3

7.43

7.42

1.07

383

1254

(3009871) Measles virus Ab [Titer] in Serum

11.64

91.33

1.4

1.6

—

(40757373) Influenza virus identified in Isolate

103

10.17

91.22

2.9

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

130

177

7.49

90.17

46.0

23.4

158.84

109.84

ug/l

7.38

106

145

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

176

328

5.51

89.79

2.2

2.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

425

1500

2.98

89.09

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

227

533

4.40

88.12

1.3

1.2

3.41

4.87

u/ml

0.99

138

230

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

216

489

4.55

87.82

1.2

1.1

119.32

114.74

1.02

205

431

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

379

1263

3.14

87.76

3.5

2.2

89.75

88.78

0.36

369

1217

(3035350) Ketones [Presence] in Urine by Test strip

3036

22629

1.74

87.47

5.0

3.9

0.00

estimate

2.37

854

4558

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

171

318

5.51

87.44

1.1

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

3028

22566

1.74

87.16

6.7

5.2

0.00

estimate

0.50

826

4203

(3009261) Glucose [Presence] in Urine by Test strip

3050

22874

1.73

84.90

5.0

4.0

0.00

estimate

1.34

801

4077

(3004588) Protein electrophoresis panel - Serum or Plasma

807

3972

2.20

83.84

2.2

2.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

919

4765

2.11

83.53

2.3

2.5

66.39

66.02

g/l

0.68

848

4270

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

353

1162

3.17

83.39

3.6

2.5

211.63

203.18

0.90

336

1109

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2246

15612

1.73

81.30

3.4

2.2

149.08

225.94

u/l

5.88

2122

14541

(3048929) Epstein Barr virus Ab [Presence] in Serum

300

911

3.42

80.77

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

711

3374

2.27

80.57

2.0

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

904

4719

2.09

80.46

10.8

6.7

1.44

1.37

mmol/l

1.00

879

4584

(3026250) Tacrolimus [Mass/volume] in Blood

110

142

7.88

79.87

40.6

31.0

8.03

7.25

ug/l

2.06

126

(3026493) Urate [Moles/volume] in Serum or Plasma

1950

13092

1.75

79.47

4.8

2.9

2201.80

5368.31

umol/l

4.50

1737

11213

(3014148) Varicella zoster virus Ab [Titer] in Serum

166

330

5.15

78.80

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1188

6880

1.92

78.54

7.7

5.7

1.05

1.04

mmol/l

1.02

1115

6343

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

109

142

7.81

78.54

2.1

2.0

—

(3028271) Lactate [Moles/volume] in Capillary blood

283

844

3.48

78.35

2.3

1.9

1.66

1.72

mmol/l

0.44

277

821

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1608

10254

1.79

78.04

5.2

4.0

423.28

493.81

ng/l

0.27

1426

8704

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

647

2992

2.31

77.81

14.2

9.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

210

512

4.22

77.58

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

146

262

5.69

77.56

1.5

1.3

0.94

2.00

u/ml

0.98

148

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

177

378

4.80

77.26

1.2

96.13

94.26

0.35

170

351

(3033658) Prothrombin time (PT) actual/Normal

1833

12196

1.74

76.47

6.3

4.1

84.86

85.34

0.33

1801

11900

(3013293) Extractable nuclear Ab [Presence] in Serum

14.63

75.86

1.6

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1138

6571

1.92

75.57

3.6

2.4

1.94

1.76

6.17

1012

5777

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

163

333

5.01

74.98

1.3

1.2

134.71

131.92

titre

0.02

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

163

333

5.01

74.98

1.3

1.2

122.00

123.64

titre

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3883

31661

1.73

74.68

6.4

4.9

721.72

1758.95

e6/l

1.41

534

(21494814) CD8 cells/100 lymphocytes in Specimen

112

162

7.03

73.58

2.0

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

941

5141

2.00

73.31

4.8

3.7

5.89

5.83

kpa

0.78

909

4976

(3002032) Base excess in Venous blood by calculation

939

5128

2.00

73.23

4.8

3.7

2.25

1.94

mmol/l

1.61

809

4297

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

166

354

4.80

72.58

2.3

—

(3036489) Thrombin time

417

1627

2.69

72.09

3.3

2.0

21.83

21.70

0.12

380

1462

(3015377) Calcium [Moles/volume] in Serum or Plasma

2350

16921

1.67

71.96

4.3

3.4

2.34

2.35

mmol/l

3.20

2145

14590

(3022313) Gas panel - Capillary blood

559

2511

2.36

71.65

6.4

4.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

172

382

4.61

71.58

1.1

—

(3017569) Oxygen content in Arterial blood

144

276

5.33

71.22

2.2

2.0

—

(3012544) pH of Venous blood

959

5323

1.97

71.19

4.7

3.7

7.42

7.37

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

136

248

5.59

71.02

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

118

189

6.36

70.39

1.7

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

118

189

6.36

70.39

1.7

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

118

190

6.32

70.02

1.7

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

753

3857

2.10

69.79

1.9

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1320

8170

1.80

69.54

4.2

3.2

1.65

1.96

e6/l

1.02

738

4646

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

134

248

5.51

68.87

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

325

1143

2.96

68.25

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

325

1143

2.96

68.25

1.5

1.3

—

(3028433) Virus identified in Specimen by Culture

103

150

6.98

67.25

1.1

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

142

287

5.05

66.13

2.1

2.0

451.82

530.49

e6/l

0.85

119

237

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

797

4251

2.02

65.91

4.8

4.0

1.22

1.23

mmol/l

1.85

730

3711

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

863

4755

1.96

64.96

2.2

0.21

0.20

g/l

1.76

805

4406

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

128

242

5.39

64.27

2.1

1.5

5.91

6.72

u/l

0.46

114

202

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

135

270

5.10

63.64

2.1

0.21

0.23

e9/l

0.45

119

234

(3014007) Fractional oxyhemoglobin in Arterial blood

677

3447

2.10

63.40

13.7

8.6

92.54

93.94

8.01

671

3434

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

544

2559

2.25

62.23

4.8

4.0

24.40

24.10

mmol/l

1.44

533

2498

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2478

18532

1.60

62.20

3.4

2.9

202.73

156.54

ug/l

6.88

2263

16806

(3023520) Reticulocytes [#/volume] in Blood

887

5002

1.92

62.10

3.4

2.5

73.81

67.95

e9/l

3.76

624

3824

(3008536) Aspergillus sp Ab [Presence] in Serum

8.51

61.33

1.6

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1361

8770

1.73

61.18

3.8

3.0

0.92

1.14

e6/l

1.72

780

5202

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1289

8219

1.74

60.02

2.8

2.0

30.01

30.11

0.25

1258

7964

(3002385) Erythrocyte distribution width [Ratio]

4370

37663

1.71

59.48

36.4

19.7

15.15

15.36

1.99

4347

36927

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2604

19847

1.58

59.31

5.1

4.1

38.12

87.77

ng/l

1.49

2085

15142

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

119

227

5.33

59.17

1.1

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

616

3121

2.09

58.20

1.7

1.5

—

(3015736) pH of Urine

2408

18083

1.58

58.09

4.2

3.7

5.79

5.80

0.02

823

(3034426) Prothrombin time (PT)

119

7.24

57.52

1.1

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

657

3432

2.03

57.09

14.1

8.6

0.64

0.66

0.85

651

3405

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

659

3449

2.03

56.95

13.9

8.4

1.39

1.32

1.21

653

3427

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1863

13268

1.60

55.74

2.5

2.3

3.22

3.04

mg/l

2.34

1626

11227

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2847

22466

1.54

53.40

3.0

2.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.77

52.65

1.1

—

(40761536) Microorganisms panel - Urine sediment

709

3923

1.92

51.92

5.5

4.2

—

(3019977) pH of Arterial blood

133

314

4.31

51.24

2.6

2.4

7.43

7.42

0.66

103

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

160

434

3.77

50.99

1.1

1.67

2.36

iu/ml

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

417

1907

2.28

50.75

2.7

3.3

60.44

90.92

mg/l

0.51

301

1577

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

416

1903

2.28

50.59

2.7

3.3

43.52

55.23

mg/l

0.79

299

1571

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

10.89

50.37

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

100

7.38

50.37

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

477

2315

2.16

50.14

5.4

5.0

1.76

1.61

3.17

452

2165

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

407

1858

2.28

49.72

2.7

3.2

2.90

3.56

ratio

0.18

141

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

115

250

4.67

49.15

2.5

2.6

38.53

37.63

0.16

145

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4945

44856

1.83

47.63

33.5

16.8

24.89

26.67

mg/l

4.07

4629

36458

(3020891) Body temperature

454

2212

2.14

47.17

5.7

4.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

426

2034

2.18

46.58

4.0

2.9

0.32

0.34

u/ml

0.68

255

1157

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

182

570

3.27

46.53

1.1

1.56

1.55

g/l

0.03

161

510

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

884

5410

1.75

46.28

4.7

3.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1632

11672

1.56

46.03

5.0

3.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

245

915

2.75

45.88

1.4

1.3

—

(4035726) Immunohistochemistry procedure

743

4349

1.82

45.19

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

15.70

45.15

1.1

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

8.48

45.03

1.3

1.2

48.61

45.56

mg/l

0.13

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

875

5388

1.74

44.69

3.1

2.7

9.69

9.39

umol/l

0.13

766

4708

(3044889) 12 lead EKG panel

3844

32974

1.52

44.45

5.7

4.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

145

5.72

44.28

2.1

1.9

8.99

12.44

1.25

128

(3024354) Oxygen [Partial pressure] in Venous blood

722

4215

1.82

44.24

3.9

3.1

4.53

4.51

kpa

0.07

694

4065

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

515

2704

2.00

43.62

2.1

1.7

1.61

1.57

g/l

0.37

434

2308

(3037756) Immunofixation for Serum or Plasma

299

1272

2.43

42.83

1.5

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

236

901

2.69

42.34

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

117

295

4.03

41.35

2.3

2.0

571.86

647.97

e6/l

0.67

109

280

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

199

4.73

40.56

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

100

6.56

40.35

1.0

—

(3047181) Lactate [Moles/volume] in Blood

364

1733

2.18

39.98

7.6

5.9

1.41

1.32

mmol/l

0.90

338

1533

(3007930) Methemoglobin/Hemoglobin.total in Blood

446

2293

2.03

39.98

5.7

5.1

0.86

0.88

0.30

419

2149

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

244

983

2.55

39.26

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

387

1903

2.11

39.10

3.5

2.2

381.87

633.90

ug/l

1.16

368

1802

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2004

15365

1.47

39.07

2.9

2.6

63.25

65.05

u/l

0.11

1856

14131

(3004809) Band form neutrophils/100 leukocytes in Blood

231

918

2.58

38.23

4.2

3.6

1.65

1.57

0.13

217

792

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

186

4.73

37.99

1.1

1.2

1.05

1.07

ratio

0.35

(3029937) Albumin [Presence] in Urine by Test strip

1680

12494

1.49

37.93

5.5

4.3

0.00

estimate

0.88

772

3983

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

419

2162

2.01

37.12

7.1

4.3

25.08

24.80

mmol/l

1.24

394

1973

(3024891) Influenza virus A+B Ag [Presence] in Specimen

248

1036

2.46

36.94

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

410

2104

2.02

36.88

2.4

2.3

3.14

2.95

g/l

3.16

379

1857

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

346

1672

2.14

36.54

2.4

2.3

0.06

0.04

g/l

0.33

322

1516

(40760888) Immunoglobulin light chains.free panel - Serum

309

1432

2.22

36.25

2.7

3.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

327

1551

2.18

36.21

2.4

2.3

0.00

g/l

0.50

303

1400

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

140

5.27

36.15

1.1

25.64

6.38

u/ml

0.54

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

148

477

3.16

36.13

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

248

1047

2.43

36.10

1.8

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

322

1521

2.18

36.03

2.5

2.3

0.00

g/l

-0.00

303

1394

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

431

2271

1.97

35.95

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

431

2273

1.97

35.85

2.3

7.90

7.44

g/l

5.52

400

2021

(3011397) Hemoglobin [Presence] in Urine by Test strip

1495

10960

1.50

35.83

4.3

3.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

430

2267

1.97

35.80

2.3

3.96

3.69

g/l

1.99

398

2020

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

406

2119

1.99

34.78

2.4

2.3

10.67

10.21

g/l

1.18

373

1850

(3018572) Chloride [Moles/volume] in Blood

274

1234

2.28

34.42

7.3

6.8

103.90

105.10

mmol/l

4.06

252

1101

(3039000) Anion gap in Blood

274

1234

2.28

34.42

7.3

6.8

11.66

11.18

mmol/l

1.56

252

1101

(3021788) Differential panel - Synovial fluid

221

905

2.50

34.36

1.6

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

321

1548

2.14

34.06

3.9

3.4

—

(3026008) Bacteria identified in Urine by Culture

2012

15740

1.43

33.97

3.6

3.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

374

1913

2.02

33.90

2.5

2.4

0.71

1.02

g/l

0.94

333

1619

(3018405) Lactate [Moles/volume] in Arterial blood

384

1991

2.00

33.50

4.8

3.8

1.38

1.42

mmol/l

0.38

379

1959

(3007853) Bacteria identified in Skin by Aerobe culture

869

5727

1.61

33.40

2.1

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

251

1109

2.32

32.97

1.3

1.2

127.78

92.30

titre

0.67

(3047007) Chlamydophila sp Ab [Presence] in Serum

141

470

3.05

32.53

1.3

1.2

—

(40768797) Stomach Pathology biopsy report

959

6536

1.56

31.80

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2157

17239

1.41

31.64

5.3

4.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

344

1752

2.03

31.53

2.4

2.2

35.99

37.47

g/l

4.36

314

1498

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1325

9711

1.48

31.05

2.9

3.2

2.48

2.46

mmol/l

6.40

1198

8464

(3034770) Mitochondria Ab [Titer] in Serum

247

1117

2.27

30.72

1.2

833.64

1007.88

titre

0.23

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

170

648

2.67

30.63

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

259

1229

2.16

28.62

3.5

3.0

1.79

1.70

mg/l

0.95

238

1103

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3179

27366

1.37

28.47

4.4

3.1

64.78

55.14

u/l

3.99

2958

24889

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

281

1388

2.08

27.97

1.6

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1151

8376

1.47

27.50

1.3

1.2

1.27

1.80

u/ml

1.35

281

2084

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

148

4.50

27.26

1.3

2.2

199.32

167.91

1.34

139

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

5.46

26.90

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

5.35

26.31

1.1

1.2

89.65

81.60

0.84

(3004119) Hemoglobin [Mass/volume] in Venous blood

541

3350

1.68

26.26

4.5

3.3

126.61

127.71

g/l

0.54

525

3264

(3000012) Reticulocyte production index

190

843

2.30

24.76

2.7

2.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

178

771

2.35

24.52

1.8

4.55

4.73

mmol/24h

0.29

161

648

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

101

5.09

24.43

1.1

1.3

91.36

81.00

0.95

(3017732) Neutrophils [#/volume] in Blood

491

3021

1.68

24.37

3.4

3.3

5.03

5.51

e9/l

0.45

405

2276

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

34.62

24.24

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

156

640

2.48

24.23

1.2

1.3

197.18

204.83

miu/ml

0.07

235

(3008757) Leukocyte morphology finding [Identifier] in Blood

146

585

2.54

23.84

4.9

4.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

139

4.35

23.82

1.0

1.1

98.89

91.42

1.42

105

(3021960) Folate [Moles/volume] in Serum or Plasma

1602

12643

1.37

23.60

1.8

1.6

18.93

20.17

nmol/l

2.78

1425

10703

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

122

455

2.72

23.02

1.9

1.4

38.38

26.47

2.67

286

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

108

4.76

22.63

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

146

600

2.47

22.61

1.7

1.5

59.48

62.02

0.32

392

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

113

412

2.78

22.27

1.7

1.8

4.55

4.61

mg/l

0.04

106

391

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

653

4398

1.55

22.26

2.8

2.4

35.47

48.86

u/l

0.65

588

3746

(3027273) Bicarbonate [Moles/volume] in Venous blood

445

2745

1.67

21.82

4.4

3.4

25.59

25.17

mmol/l

1.51

427

2656

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

300

1653

1.86

21.75

1.4

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

204

984

2.11

21.66

1.6

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

259

1369

1.93

21.32

1.7

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

232

1187

2.00

20.99

1.9

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

602

4041

1.55

20.77

1.7

1.66

1.55

1.96

508

3408

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

108

4.57

20.74

1.7

1.4

7.85

9.30

ug/l

1.51

108

(3036782) Glucose [Moles/volume] in Pleural fluid

142

600

2.40

20.73

1.4

6.64

6.40

mmol/l

0.36

128

555

(3000060) B lymphocytes [#/volume] in Blood

4.87

20.56

2.3

1.9

128.64

1667.18

e6/l

0.84

(40768804) Tissue Pathology biopsy report

2216

18633

1.31

20.52

2.4

2.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

409

2510

1.68

20.43

3.9

2.7

0.67

0.64

0.92

409

2495

(3044242) Glucose [Moles/volume] in Arterial blood

300

3.00

20.27

1.7

1.9

—

(3051651) Icteric interference index of Serum or Plasma

295

3.01

20.23

5.3

3.6

—

(3025941) Bacteria identified in Stool by Culture

382

2313

1.70

20.06

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.92

19.88

1.4

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.46

19.75

1.2

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

234

1229

1.94

19.65

1.8

1.6

14188.70

14826.13

e6/l

0.06

177

881

(3045142) Bone marrow Pathology biopsy report

141

610

2.35

19.54

1.5

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

164

762

2.19

19.19

1.2

1.3

—

(3004451) EKG impression Narrative

289

2.97

19.09

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

133

4.01

19.01

2.1

2.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

174

831

2.13

18.99

3.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

224

3.24

18.79

1.8

1.4

3.84

4.09

0.06

(40768795) Lymph node Pathology biopsy report

114

461

2.50

18.34

1.4

1.2

—

(3044941) Cell count panel - Synovial fluid

166

791

2.13

18.24

1.7

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

116

476

2.47

18.10

1.3

15.54

13.16

u/l

0.48

104

436

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

111

447

2.51

18.03

1.6

1.4

14.37

13.17

u/l

0.92

106

427

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3663

33221

1.29

17.84

4.1

3.9

14.95

15.00

pmol/l

0.51

3320

29595

(3016650) Hepatitis A virus Ab [Presence] in Serum

139

623

2.26

17.78

1.2

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

644

4541

1.47

17.43

2.4

2.1

188.58

164.98

ug/g

0.69

533

3540

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

116

486

2.42

17.32

1.1

1.2

63.98

64.88

u/l

0.05

107

433

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

137

618

2.25

17.27

1.4

1.3

492.30

330.56

u/l

1.78

126

584

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

368

2305

1.64

16.96

2.7

1.9

—

(3012516) Albumin [Mass/volume] in Urine

1878

15771

1.29

16.54

3.7

3.3

735.46

311.29

mg/l

2.43

1259

10201

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.10

16.44

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

573

3995

1.48

16.38

4.3

3.8

105.71

96.77

ng/l

0.98

503

3372

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

4.60

16.31

2.0

1.8

6.97

9.02

mg/l

1.23

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

562

3908

1.49

16.27

3.6

2.7

54.93

61.46

ml/min/173m2

4.50

273

1652

(3040151) Glucose [Moles/volume] in Capillary blood

137

637

2.18

16.06

12.0

19.1

7.46

7.49

mmol/l

0.02

121

526

(3000093) Morphology [Interpretation] in Blood Narrative

118

516

2.31

16.03

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

273

1604

1.74

16.00

1.4

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

129

587

2.23

15.95

1.4

—

(40761511) CBC panel - Blood by Automated count

4833

45807

1.38

15.75

26.3

16.1

—

(3012441) Differential panel - Pleural fluid

143

682

2.13

15.73

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.44

15.62

1.6

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2458

21435

1.26

15.58

2.2

2.1

90.80

93.14

pmol/l

1.66

1364

11237

(3019309) Folate [Moles/volume] in Red Blood Cells

1344

10890

1.31

15.33

1.9

1.8

1175.07

1166.31

nmol/l

0.12

1010

8121

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

264

2.83

15.31

4.6

3.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2541

22275

1.26

15.29

3.3

2.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4954

47205

1.40

15.13

34.5

19.9

139.09

139.64

mmol/l

40.03

4903

45956

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.95

14.97

1.0

1.3

93.27

79.26

0.62

(3009508) Creatinine [Moles/volume] in Urine

1899

16124

1.27

14.90

3.6

3.2

7.14

7.38

mmol/l

1.77

1583

13317

(3050794) Legionella sp Ab [Presence] in Serum

6.12

14.64

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

171

894

1.94

14.63

1.5

32.18

31.54

g/l

0.25

148

799

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

4.80

14.46

1.2

105.42

1325.25

ng/l

0.51

(3023103) Potassium [Moles/volume] in Serum or Plasma

4955

47299

1.39

14.22

34.8

20.1

4.01

4.00

mmol/l

3.56

4897

45982

(3020682) Albumin/Creatinine [Ratio] in Urine

1947

16651

1.26

14.19

4.3

3.8

12.17

9.55

mg/mmol

1.43

1266

10581

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

333

2.55

14.18

1.4

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

304

2.62

14.17

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

200

1115

1.82

14.04

4.0

3.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.79

13.99

1.1

1.2

76.70

84.00

—

(3023183) Ammonium ion [Moles/volume] in Plasma

199

1111

1.82

13.91

2.8

2.5

33.23

34.49

umol/l

0.29

187

987

(3017354) Segmented neutrophils/100 leukocytes in Blood

120

565

2.15

13.69

4.4

3.5

56.12

57.22

0.23

106

459

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

329

2.51

13.52

1.4

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

144

730

2.00

13.49

7.0

6.3

12.13

11.99

mg/l

0.15

133

671

(3010726) Horse dander IgE Ab [Units/volume] in Serum

327

2.50

13.20

1.1

1.61

1.11

u/ml

0.28

169

(40768806) Pleura Pathology biopsy report

136

684

2.01

13.04

1.5

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.92

13.04

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4953

47398

1.37

12.93

35.6

19.9

87.65

83.24

umol/l

9.29

4953

47384

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

439

2.25

12.67

1.1

1.40

2.20

u/ml

0.44

231

(40768446) Kidney Pathology biopsy report

155

3.18

12.56

1.4

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

113

541

2.11

12.39

4.5

3.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

239

1456

1.67

12.32

1.4

1.5

293.85

265.21

ug/g

0.47

147

874

(3027456) Digoxin [Moles/volume] in Serum or Plasma

216

1285

1.71

12.17

3.0

3.1

0.85

0.83

nmol/l

0.33

171

965

(40768443) Skin Pathology biopsy report

331

2188

1.54

12.16

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

190

2.91

12.14

4.8

3.9

58.83

54.58

0.69

183

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

197

1145

1.75

12.07

1.3

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

323

2133

1.55

11.93

2.3

1.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

129

659

1.98

11.88

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4468

42272

1.27

11.80

7.0

6.4

41.44

40.75

mmol/mol

3.65

4156

38465

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

279

2.53

11.76

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

279

2.53

11.76

1.5

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4333

40853

1.26

11.73

5.1

4.7

2.09

mu/l

0.01

3960

36619

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

141

748

1.91

11.63

1.1

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

230

2.67

11.46

1.1

1.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4939

47390

1.34

11.44

20.7

11.1

24.92

25.65

u/l

2.00

4881

45344

(3014133) Dog dander IgE Ab [Units/volume] in Serum

277

2.51

11.43

1.0

1.1

2.87

2.61

u/ml

0.07

133

(3003888) Timothy IgE Ab [Units/volume] in Serum

382

2.27

11.39

1.1

3.82

3.79

u/ml

0.01

181

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

231

2.66

11.37

1.1

1.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4458

42224

1.27

11.30

28.6

16.0

73.52

74.55

ml/min/173m2

2.54

4007

35034

(3023430) Cat dander IgE Ab [Units/volume] in Serum

255

2.57

11.29

1.0

1.1

1.52

3.36

u/ml

0.90

100

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1335

11175

1.25

11.17

1.8

1.7

28319877.09

28019803.07

pmol/l

0.01

1077

9083

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

179

2.87

10.98

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

244

2.56

10.72

1.1

—

(3045788) Cell count panel - Pleural fluid

118

608

1.96

10.64

1.6

1.5

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

5.27

10.57

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

151

3.00

10.50

1.1

1.2

—

(3044927) Protein electrophoresis panel - Urine

117

604

1.96

10.50

1.2

—

(36660697) Celiac disease serology panel - Serum

421

3037

1.42

9.98

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

372

2.19

9.95

1.1

0.46

1.46

u/ml

1.36

159

(3017704) Immunofixation for Urine

329

2.27

9.83

1.3

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

293

2.34

9.72

1.4

1.6

8.92

7.09

u/l

0.46

240

(3022145) Colonoscopy Study observation

667

5204

1.32

9.62

1.4

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

222

2.54

9.58

1.0

0.22

0.29

u/ml

0.15

(3032743) Legionella sp IgG Ab [Presence] in Serum

7.12

9.48

1.1

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

7.12

9.48

1.1

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.52

9.39

1.1

1.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

288

2.31

9.19

1.1

1.2

97.46

91.59

u/l

0.21

246

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

276

2.33

9.15

1.1

1.2

44.81

24.39

u/l

1.32

232

(3035880) pH of Pleural fluid

369

2.13

8.94

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1773

15592

1.20

8.78

3.2

2.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.25

8.60

1.3

1.5

3.73

6.27

0.72

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

631

4971

1.30

8.46

1.4

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.65

8.34

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.65

8.34

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.65

8.34

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

243

1639

1.50

8.22

1.1

335.83

233.71

titre

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

100

535

1.88

8.17

2.6

3.2

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

8.91

8.02

1.6

1.2

2.68

2.66

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

8.91

8.02

1.6

1.2

1.47

3.53

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

8.91

8.02

1.6

1.2

2.78

1.25

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

8.91

8.02

1.6

1.2

2.50

0.62

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

8.91

8.02

1.6

1.2

5.48

2.23

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

8.91

8.02

1.6

1.2

0.87

0.92

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

8.91

8.02

1.6

1.2

5.19

1.24

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

8.91

8.02

1.6

1.2

2.17

3.32

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

8.91

8.02

1.6

1.2

1.03

1.31

mg/l

—

(3012565) Volume of 24 hour Urine

242

2.33

8.02

2.0

2.4

1892.78

1875.96

0.05

203

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

10.02

8.01

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

212

2.42

7.96

6.5

4.4

64.19

69.06

mg/l

0.26

148

(3023199) Leukocytes [#/volume] in Pleural fluid

134

791

1.71

7.91

1.6

1.5

5498.08

1850.08

e6/l

0.65

575

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

8.44

7.80

1.6

1.3

0.14

2.17

mg/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

204

2.41

7.64

1.1

10.09

13.48

iu/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

123

718

1.73

7.57

1.5

126418.14

61308.84

e6/l

0.72

427

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.59

7.56

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

380

2827

1.37

7.54

2.6

2.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

638

5112

1.28

7.49

2.7

2.4

11.50

6.80

ug/l

4.39

559

4414

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

352

2.03

7.27

1.1

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.83

7.24

1.2

1.0

10.42

7.10

iu/ml

0.29

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

227

1552

1.48

7.23

1.1

0.88

1.25

u/ml

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

514

6486

0.77

7.13

9.6

8.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

153

2.56

6.92

1.1

14.30

2.09

u/ml

1.10

(40761539) Cells [Type] in Urine sediment by Light microscopy

130

2.70

6.91

1.3

1.1

—

(21494434) Karyotype in Bone marrow

486

1.84

6.89

1.4

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

208

2.32

6.88

1.5

1.4

1.33

2.61

0.94

176

(3041918) Cholesterol [Moles/volume] in Pleural fluid

119

2.78

6.88

1.2

1.89

1.53

mmol/l

0.83

(3023383) Lactate [Moles/volume] in Pleural fluid

202

2.34

6.87

1.3

4.07

3.54

mmol/l

0.44

181

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

480

1.85

6.84

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

10.93

6.79

1.2

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

312

2288

1.38

6.79

2.6

3.3

4.22

4.39

pmol/l

1.75

267

1991

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

9.30

6.77

1.7

1.2

—

(3045424) Erythrocytes [Presence] in Urine

131

806

1.64

6.68

1.8

1.5

—

(3020491) Glucose [Moles/volume] in Blood

350

1.98

6.67

2.2

2.3

7.41

6.85

mmol/l

1.04

228

(3016750) Collection duration of Urine

305

2.04

6.52

2.1

2.0

475.88

493.43

min

0.58

210

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1381

12158

1.18

6.38

1.8

1.6

1.43

1.33

mmol/l

4.73

1123

10075

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1355

11941

1.18

6.15

3.0

2.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.52

6.15

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

105

624

1.70

6.14

1.7

2.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

188

2.30

6.08

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.11

6.08

1.3

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

470

1.80

6.06

1.2

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

5010

48779

1.24

6.03

45.4

24.8

39.48

39.77

1.37

4646

44978

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

254

2.10

6.01

1.4

65.73

67.83

0.13

208

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

378

1.89

6.00

1.7

1.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.34

5.99

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

693

5755

1.23

5.94

3.2

4.0

13.86

22.65

ug/l

1.03

567

4771

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

150

984

1.54

5.88

1.1

19.85

8.74

u/ml

0.65

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

5.78

5.82

2.0

1.21

1.48

mg/l

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.82

5.82

1.4

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

312

1.97

5.81

1.0

291.89

285.75

mg/l

0.27

275

(3024731) MCV [Entitic volume]

5010

48812

1.23

5.78

44.3

24.6

92.53

91.59

34.03

4974

47917

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

383

1.86

5.78

1.7

1.3

—

(3035941) MCH [Entitic mass]

5010

48813

1.23

5.77

44.2

24.6

30.52

30.44

1.92

4975

47918

(3007461) Platelets [#/volume] in Blood

5009

48804

1.23

5.76

44.5

24.7

244.78

241.09

e9/l

3.28

4935

47339

(3026361) Erythrocytes [#/volume] in Blood

5010

48815

1.23

5.75

44.4

24.7

4.36

4.43

e12/l

16.37

4918

47166

(3010813) Leukocytes [#/volume] in Blood

5010

48816

1.23

5.75

44.4

24.7

7.78

6.87

e9/l

60.43

4922

47149

(3013512) EKG study

1685

15174

1.16

5.73

5.1

4.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.24

5.71

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.34

5.71

1.3

11.09

158007.68

nmol/l

0.49

(3000963) Hemoglobin [Mass/volume] in Blood

5010

48825

1.23

5.68

44.8

24.8

131.59

133.91

g/l

21.96

4974

47944

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

163

1101

1.49

5.59

1.6

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

283

1.99

5.53

1.8

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

283

1.99

5.53

1.8

1.3

—

(3003181) Sodium [Moles/volume] in Urine

143

944

1.53

5.48

1.4

1.3

65.53

63.08

mmol/l

0.32

129

760

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

167

2.28

5.35

3.5

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

167

2.28

5.35

3.5

2.4

—

(44813793) Dust mix specific IgE antibody measurement

240

2.05

5.29

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

511

6228

0.80

5.25

4.7

4.9

31.95

33.20

1.80

374

4099

(3011648) Oxygen content in Venous blood

398

1.79

5.15

5.6

2.3

11.12

10.95

0.13

398

(3006576) Bicarbonate [Moles/volume] in Blood

177

2.21

5.11

5.9

7.0

24.21

24.61

mmol/l

0.22

161

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

128

2.43

5.03

1.4

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

130

2.39

4.88

6.4

7.4

—

(3047189) Immunofixation for 24 hour Urine

298

1.89

4.81

1.7

1.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

5.21

4.76

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

388

1.76

4.69

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

2.71

4.67

2.2

3.2

6.06

6.82

mg/l

0.21

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

133

898

1.49

4.64

1.2

1.3

47.55

40.89

u/l

0.15

116

777

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

121

2.40

4.62

1.6

1.5

0.37

0.43

ug/l

0.39

(3024263) Appearance of Synovial fluid

290

1.87

4.54

1.8

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

3.06

4.51

1.1

9.82

8.25

u/ml

—

(3003694) ABO and Rh group [Type] in Blood

1290

11576

1.15

4.44

1.5

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.01

4.39

1.1

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

389

1.73

4.37

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

489

1.65

4.33

1.8

1.3

93154.86

113863.83

e6/l

0.12

337

(3004775) Volume in Urine collected for unspecified duration

444

1.68

4.30

2.2

559.73

654.32

1.41

268

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

6.26

4.29

1.0

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

514

4283

1.22

4.29

1.6

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

239

1.93

4.28

1.4

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

6.93

4.16

1.1

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

6.93

4.16

1.1

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

2.59

4.13

1.3

14.07

21.90

0.48

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

188

2.03

4.07

2.9

2.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

237

1.91

4.05

1.4

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.51

4.04

1.3

1.2

—

(3019150) Specific gravity of Urine by Refractometry

1134

10153

1.15

4.00

5.3

4.4

1.02

kg/l

0.34

200

1580

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.90

3.99

1.1

0.09

0.08

g/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

100

659

1.53

3.97

1.7

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

163

2.09

3.96

1.2

1.4

23.57

22.09

0.11

134

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.79

3.88

1.3

0.82

0.80

ml/s/173m2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

284

1.80

3.87

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

306

1.77

3.87

2.4

2.6

23.36

32.56

umol/l

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

199

1.97

3.86

1.2

1.3

111.19

547.91

ug/l

1.12

102

(3024522) Salmonella sp identified in Specimen by Organism specific culture

100

665

1.51

3.82

1.6

1.4

—

(40758292) HTLV I+II Ab panel - Serum

2.84

3.78

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

660

1.51

3.75

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

660

1.51

3.75

1.7

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

172

1270

1.37

3.74

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

173

1279

1.36

3.74

1.3

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

662

1.50

3.70

1.7

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.01

3.68

1.0

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

112

771

1.46

3.64

1.4

31.83

30.97

iu/l

0.09

651

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

100

674

1.49

3.61

1.7

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

366

1.67

3.60

1.4

124.00

322.75

titre

—

(3037121) Protein [Mass/volume] in Urine

231

1798

1.30

3.52

2.8

3.1

0.39

0.32

g/l

0.65

116

759

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

169

1259

1.35

3.50

1.3

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

332

1.69

3.47

2.9

2.5

—

(3001729) Color of Synovial fluid

2.89

3.46

2.5

1.5

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.54

3.45

1.5

1.4

69.21

74.58

0.30

(21494755) Public health laboratory ask at order entry panel

146

1977

0.73

3.45

1.3

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

433

1.60

3.44

1.6

13.55

25.41

u/ml

2.12

(3020393) Adenovirus Ag [Presence] in Stool

2.98

3.41

1.1

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.35

3.40

1.2

0.45

1.93

mmol/l

1.30

(3038071) Oxygen [Partial pressure] in Mixed venous blood

114

2.20

3.34

6.0

7.6

—

(3020650) Glucose [Presence] in Urine

2.32

3.33

1.9

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

175

1.95

3.32

1.2

1.1

33.33

40.39

g/l

2.13

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

178

2323

0.76

3.28

1.9

1.8

—

(40768441) Liver Pathology biopsy report

301

1.70

3.23

1.5

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.80

3.08

1.4

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

283

1.70

3.07

1.9

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

5.01

3.05

1.3

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4500

43932

1.12

2.95

5.3

5.1

6.07

6.08

mmol/l

0.28

4056

39282

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.83

2.91

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.70

2.88

1.9

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.71

2.87

1.1

1.0

—

(3002256) Pathology report gross observation

712

6323

1.14

2.82

1.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.45

2.79

8.1

8.7

—

(3045414) Leukocytes [Presence] in Urine

265

2164

1.24

2.78

2.3

2.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

159

1.89

2.74

3.0

2.1

195.61

116.92

umol/l

0.31

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

6.01

2.69

1.3

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

405

1.54

2.68

1.9

4857.03

2594.96

u/l

0.24

152

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

110

1489

0.73

2.67

1.7

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

652

1.42

2.66

1.6

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.55

2.61

4.1

4.7

—

(3016038) Potassium [Moles/volume] in Urine

353

1.56

2.58

1.3

1.1

32.95

34.42

mmol/l

0.22

303

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

268

2212

1.22

2.56

1.2

128.78

141.37

iu/ml

0.20

778

(3020876) Protein [Mass/time] in 24 hour Urine

657

1.41

2.56

2.5

2.4

0.98

1.36

g/24h

0.94

326

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.36

2.55

1.2

18.13

19.98

u/l

—

(3016135) IgD [Mass/volume] in Serum

7.15

2.55

1.4

1.3

242.20

121.46

mg/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

414

3567

1.17

2.48

2.6

2.1

12.27

12.09

nmol/l

0.18

356

3086

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.38

2.46

1.6

1.2

109.73

124.11

ug/l

—

(40765096) Chromosome analysis panel by Banding

173

1.80

2.45

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

554

1.43

2.44

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

130

1.93

2.44

1.0

1.1

1707.08

1647.75

miu/ml

0.07

130

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

123

1.96

2.44

1.3

0.35

0.30

g/l

1.28

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4286

41860

1.10

2.41

4.4

4.2

1.35

1.28

mmol/l

8.76

3806

37367

(3048879) Bone marrow aspiration report

167

1.80

2.40

2.1

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

212

1.70

2.38

1.1

1.6

5.75

11.12

umol/l

1.06

144

(3041184) Isoniazid [Presence] in Urine

6.25

2.37

2.6

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.50

2.35

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.82

2.34

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.22

2.30

1.6

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

245

1.64

2.30

1.5

1.3

1.26

1.16

nmol/l

0.20

184

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

215

1.68

2.28

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

325

1.54

2.26

1.2

1.3

1.17

1.14

promille

0.06

245

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.02

2.25

1.2

0.86

98.32

mg/l

0.80

(3004716) Salmonella sp identified in Stool by Organism specific culture

205

1673

1.23

2.23

1.4

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

297

2520

1.19

2.17

1.3

49.05

62.78

au/ml

0.36

138

(3009214) Lutropin [Units/volume] in Serum or Plasma

103

773

1.34

2.17

1.4

11.24

10.50

u/l

0.22

621

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.69

2.15

1.3

1.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.00

2.07

2.4

4.1

—

(3044009) aPTT.lupus sensitive (LA screen)

2.82

2.00

1.3

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

193

1.66

1.99

2.9

2.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.34

1.96

2.3

5.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.73

1.93

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1141

0.75

1.92

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

323

2795

1.17

1.90

2.4

31.35

23.27

au/ml

0.28

153

(3008295) Osmolality of Serum or Plasma

515

1.38

1.89

1.4

1.3

273.22

277.66

mosm/kgh2o

0.83

388

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

275

1.53

1.89

1.6

1.8

1.76

2.20

u/field

0.23

187

(3049717) Cytology report of Urine Cyto stain

286

2453

1.17

1.88

2.9

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

1.88

0.0

5.8

—

8.03

—

(3008898) HLA-B27 [Presence]

127

1004

1.27

1.87

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

107

1.87

1.85

1.2

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

205

1.61

1.85

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

433

1.41

1.84

1.3

1.4

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

190

1.64

1.83

1.5

1.4

28.29

20.22

0.67

174

(4034850) Laboratory test

182

1503

1.22

1.82

12.5

11.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

692

1.32

1.81

3.1

2.1

25.56

26.51

mg/l

0.06

159

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

327

0.55

1.80

1.4

1.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.57

1.80

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

153

1.70

1.79

1.0

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

231

1.56

1.78

1.3

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

176

1453

1.22

1.78

1.6

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.93

1.74

1.3

1.2

22.10

415.99

u/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

201

1.60

1.73

1.3

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

125

1.76

1.71

2.1

2.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

230

1962

1.18

1.65

3.1

3.4

172.19

2832.76

u/ml

1.17

187

1682

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4444

43691

1.08

1.62

5.0

4.7

4.39

4.47

mmol/l

6.23

4003

39708

(3035933) Granulocytes/100 leukocytes in Blood

1.91

1.59

2.4

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.95

1.59

1.3

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4554

44836

1.08

1.55

5.5

5.3

2.51

2.60

mmol/l

9.95

4103

40524

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.27

1.55

1.2

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.88

1.54

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

424

1.37

1.53

1.0

1.1

15.71

2.47

u/ml

0.80

139

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

1.51

0.0

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4401

43289

1.08

1.50

4.9

4.7

1.40

1.43

mmol/l

4.47

3931

39041

(3003338) MCHC [Mass/volume]

3674

35921

1.07

1.50

39.8

22.1

329.50

331.86

g/l

44.94

3654

35578

(3032773) Endomysium IgG Ab [Titer] in Serum

309

1.43

1.47

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.37

1.45

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.12

1.44

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.73

1.43

4.0

8.9

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.31

1.43

1.1

1.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

188

1.55

1.42

1.6

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.82

1.41

5.3

7.4

—

(3022621) pH of Urine by Test strip

367

3286

1.12

1.38

4.0

3.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

104

1.73

1.36

1.6

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

112

1.70

1.35

1.2

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.78

1.28

1.2

1.9

4.18

4.44

mmol/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.78

1.28

1.0

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.05

1.26

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

105

858

1.23

1.26

1.2

1.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.00

1.23

1.0

1.3

—

mmol/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.91

1.22

2.0

1.4

36.25

43.59

umol/l

0.63

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

685

0.76

1.21

1.5

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.16

1.21

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

180

1.50

1.20

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

124

1.62

1.20

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

165

1.52

1.17

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

578

1.27

1.17

1.6

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.16

1.0

—

(3015183) Erythrocyte sedimentation rate

142

1.55

1.14

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

812

0.79

1.14

1.7

1.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.33

1.12

1.0

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.33

1.12

2.7

3.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.38

1.09

1.0

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

375

0.69

1.08

1.0

289.19

327.07

ng/l

0.30

248

(3019174) dRVVT (LA screen)

2.19

1.08

1.4

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.19

1.08

1.0

—

(3014891) Appearance of Pleural fluid

1.69

1.07

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.67

1.03

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

108

0.46

1.00

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

139

1.51

1.00

2.0

1.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.97

0.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.95

0.97

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.63

0.97

1.1

1.09

0.67

u/ml

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

377

0.71

0.96

1.0

32.06

44.95

ng/l

0.77

246

(3036180) Methadone [Presence] in Urine

1.65

0.94

1.1

1.5

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

375

0.72

0.94

1.0

857.25

689.38

ng/l

1.22

241

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

197

0.61

0.93

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

197

0.61

0.93

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

226

1.37

0.92

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

196

0.61

0.92

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

196

0.61

0.92

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

754

1.20

0.91

1.3

1.7

312.78

301.70

mu/l

0.13

696

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

279

0.68

0.90

2.0

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

456

1.25

0.89

1.7

2.0

1.64

1.75

u/field

0.07

162

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

282

1.31

0.84

1.8

1.5

0.17

0.26

nmol/l

1.80

212

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

112

1.52

0.84

1.4

1.1

305.00

267.09

pmol/l

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

104

1.54

0.84

2.0

3.3

—

(3025130) Human papilloma virus identified in Specimen

283

1.31

0.83

1.9

1.7

—

(3011288) Drugs identified in Urine by Screen method

342

0.73

0.82

13.0

2.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

736

1.18

0.81

3.5

2.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

249

1.33

0.81

1.8

1.5

0.97

0.92

g/l

0.39

249

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.65

0.81

11.0

13.4

5.72

5.30

mmol/l

0.43

(1002224) Polysomnography panel

144

1269

1.14

0.80

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

147

1.43

0.80

1.6

1.9

—

(3016018) Differential panel - Cerebral spinal fluid

437

1.24

0.79

1.2

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1650

17008

0.96

0.78

4.3

4.7

21.92

22.13

0.21

762

9016

(3020874) Milk IgE Ab [Units/volume] in Serum

131

1.45

0.78

1.0

1.1

0.72

1.97

u/ml

0.82

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.77

0.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

566

1.20

0.77

1.6

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

222

0.67

0.77

1.3

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

751

1.17

0.76

3.5

2.4

4.13

4.10

mmol/l

0.32

742

(3035285) Chloride [Moles/volume] in Venous blood

751

1.17

0.76

3.5

2.4

105.68

105.57

mmol/l

0.09

742

(40768793) Breast Pathology biopsy report

101

872

1.16

0.76

1.5

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

183

1.37

0.75

1.4

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.08

0.74

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.08

0.74

3.6

2.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

762

1.17

0.74

2.0

1.9

199.42

199.68

pmol/l

0.01

708

(1761482) Bacteria [#/volume] in Urine by Culture

133

1503

0.88

0.73

5.1

4.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.61

0.72

1.2

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

609

1.18

0.70

1.6

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

101

1.49

0.70

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.55

0.69

1.8

2.6

0.22

0.41

u/field

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.67

0.68

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

222

1.31

0.68

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

240

1.29

0.67

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

156

0.64

0.67

1.6

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.79

0.66

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.79

0.66

1.0

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

188

1708

1.10

0.66

1.5

1.7

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

202

0.69

0.65

1.4

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.54

0.65

2.1

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

120

1.42

0.64

1.8

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.47

0.64

1.6

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

165

0.67

0.62

1.4

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

647

1.16

0.60

1.1

72.36

66.39

iu/ml

0.04

130

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.60

0.0

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

224

2068

1.09

0.58

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

455

1.19

0.58

1.3

1.51

1.48

nmol/l

0.07

404

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

301

1.23

0.56

2.3

2.1

66.00

206.85

ug/min

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

700

0.86

0.56

1.9

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

150

1364

1.10

0.55

2.4

2.2

132.00

100.65

ug/min

0.48

787

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

266

1.24

0.55

1.2

1.1

46.24

44.62

mg/l

0.08

222

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

101

899

1.13

0.54

1.9

1.5

1.06

0.81

nmol/l

1.95

744

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

106

947

1.12

0.54

1.1

1.2

3.86

3.88

mmol/l

0.07

879

(3047352) Trisomy 18 risk [Likelihood] in Fetus

159

0.69

0.54

1.3

1.4

—

(3000330) Specific gravity of Urine by Test strip

257

2754

0.93

0.54

4.5

3.7

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.48

0.53

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

158

0.70

0.52

1.3

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

128

1162

1.10

0.50

2.9

3.2

276.49

834.30

u/ml

1.02

116

1060

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.49

0.49

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.49

0.49

2.2

—

(40761535) Cells panel - Urine sediment

457

4359

1.05

0.48

4.5

3.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.52

0.48

1.0

—

(4281824) Cell count and differential, peritoneal fluid

431

0.83

0.47

1.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

531

1.15

0.47

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

119

1081

1.10

0.47

1.2

1.3

740.88

549.04

mg/l

0.39

110

1014

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

626

1.14

0.46

1.5

1.3

12.76

0.66

nmol/l

0.49

596

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

277

0.79

0.46

1.0

1.1

4.26

7.93

nmol/l

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.43

0.46

1.0

—

(40768800) Prostate Pathology biopsy report

130

1420

0.91

0.45

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

630

0.87

0.44

4.4

4.5

333.58

347.56

umol/l

0.26

535

(3016330) Potassium [Moles/time] in 24 hour Urine

1.37

0.44

1.7

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

130

1.31

0.43

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

139

1.30

0.43

1.2

1.5

16.75

15.45

pmol/l

0.35

109

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

140

0.71

0.43

1.6

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

631

1.13

0.42

1.5

1.3

0.14

0.30

nmol/l

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

565

1.13

0.42

1.2

1.3

313.61

282.04

pmol/l

0.28

470

(3013139) Helicobacter pylori Ag [Presence] in Stool

277

2929

0.94

0.42

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

230

1.22

0.42

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.63

0.42

9.2

6.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

463

1.15

0.41

1.2

7.25

7.64

mmol/l

0.55

387

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.41

0.0

1.1

—

7.86

—

(3000285) Sodium [Moles/volume] in Blood

1.39

0.40

1.3

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.43

0.39

1.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.1

—

266.84

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

400

1.15

0.38

1.1

—

27.84

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

846

1.10

0.38

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

557

0.88

0.37

1.6

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

116

0.69

0.36

1.1

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2150

21205

1.02

0.35

4.9

5.5

3.49

3.78

ug/l

0.15

1888

18833

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

117

1.28

0.35

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.40

0.35

1.2

4.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.36

0.34

2.0

2.1

14.40

18.02

umol/l

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.30

0.33

1.3

—

640.53

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.28

0.32

15.5

9.7

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

341

1.14

0.32

3.4

5.0

128.80

58.02

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.33

0.32

2.5

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

295

0.85

0.32

1.2

1.4

25.27

31.25

u/l

0.59

238

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

157

1.21

0.29

17.1

12.3

806.37

833.00

nmol/l

0.09

147

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.23

0.29

1.3

2.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

121

1.24

0.28

1.0

1.1

0.67

2.89

u/ml

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

190

1807

1.05

0.28

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

119

0.76

0.27

1.1

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

923

1.07

0.27

1.5

1.7

4.50

4.78

iu/l

0.09

294

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

168

1.19

0.27

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

243

1.15

0.26

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

119

1118

1.07

0.26

2.1

1.7

26.93

3.62

mg/l

6.49

106

832

(3036071) Salmonella sp Ab [Titer] in Serum

113

1.24

0.26

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.70

0.26

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

141

1.21

0.26

1.6

1.9

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

123

1.22

0.25

1.7

1.4

120.40

258.48

nmol/24h

0.66

123

(3023487) Leukocytes [#/volume] in Peritoneal fluid

181

0.83

0.25

1.7

2.1

356.50

5007.48

e6/l

—

130

(3025577) Chromium [Mass/volume] in Blood

378

1.11

0.24

1.7

2.0

1.66

2.14

ug/l

1.07

317

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

350

1.12

0.24

1.1

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

124

1.21

0.24

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

124

1.21

0.24

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

161

1534

1.05

0.23

1.6

—

(3014271) Vancomycin [Susceptibility]

341

1.12

0.23

2.9

3.1

—

(3006462) Nitrate [Presence] in Urine

247

1.13

0.22

5.2

4.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.19

0.21

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.19

0.21

1.0

1.2

8.80

11.93

u/l

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.21

0.0

6.9

—

45.27

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

2.21

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

173

1.16

0.20

1.5

1.3

139.45

158.98

mmol/24h

0.64

173

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

117

1.20

0.20

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

0.81

0.20

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

509

1.08

0.20

1.9

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.20

0.19

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

404

1.09

0.19

1.3

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.15

0.19

2.0

1.1

1.72

1.76

umol/24h

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

156

1.15

0.18

1.1

1.0

—

(1761868) Lipid panel - Serum or Plasma

1330

13150

1.01

0.18

3.3

3.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.19

0.18

1.0

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.19

0.18

1.1

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

922

1.05

0.17

1.2

1.4

111.28

994.59

e6/l

3.61

749

(3006442) Creatine [Moles/volume] in Serum or Plasma

310

0.90

0.17

2.0

1.6

81.11

91.16

umol/l

1.40

310

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

195

1.13

0.17

1.0

1.1

1.04

1.15

u/l

1.04

102

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

243

1.11

0.17

3.9

6.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.74

0.17

2.8

2.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.18

0.16

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

101

1.19

0.16

1.2

1.1

—

(3019225) pH of Specimen

545

5353

1.02

0.16

5.5

4.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.10

0.15

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

112

1.16

0.14

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

198

1.11

0.14

1.2

1.4

—

(3027008) Opiates [Presence] in Urine

518

1.06

0.14

1.9

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

276

1.09

0.13

2.3

2.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

440

4325

1.02

0.13

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

232

0.90

0.13

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

263

0.91

0.13

1.5

1.4

125.83

199.73

pmol/l

1.18

263

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

922

1.04

0.13

1.2

1.4

18.07

26.17

e6/l

0.28

712

(3028300) Cannabinoids [Presence] in Urine

520

1.06

0.13

1.8

—

(3051593) INR in Capillary blood by Coagulation assay

303

0.92

0.12

7.1

12.8

—

(3028707) Methadone [Presence] in Urine by Screen method

249

1.08

0.11

2.5

2.2

—

(3011985) Renin [Units/volume] in Plasma

612

1.05

0.11

1.3

1.4

45.59

58.43

mu/l

0.40

533

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

136

0.88

0.11

2.0

1.15

1.31

ug/l

0.13

127

(4094501) Cardiovascular stress test using bicycle ergometer

121

1246

0.97

0.10

1.1

—

(4146454) Self-monitoring of blood glucose

633

1.04

0.10

2.5

2.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

555

1.05

0.10

1.6

1.3

—

nmol/l

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.11

0.09

1.0

—

(3026480) Teichoate Ab [Titer] in Serum

1.04

0.09

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

184

1.09

0.09

1.0

1.1

—

(4212803) Bone marrow aspirate examination

1.07

0.08

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

481

1.04

0.07

2.0

1.8

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.83

0.07

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

109

1115

0.98

0.07

6.5

3.8

29.21

30.07

mg/l

0.09

718

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.87

0.06

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

109

1069

1.02

0.05

1.6

1.7

—

(3033799) Differential panel - Peritoneal fluid

161

0.93

0.05

2.1

1.9

—

(3000764) Benzodiazepines [Presence] in Urine

516

1.03

0.04

1.9

1.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

178

1793

0.99

0.02

2.9

3.9

57.24

75.41

u/ml

0.49

171

1721

(1001926) Buprenorphine [Presence] in Urine by Screen method

401

1.02

0.02

2.2

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

297

0.98

0.01

1.1

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1205

12039

1.00

0.01

3.0

3.3

0.72

0.81

ug/l

2.50

868

8624

(3033923) Metanephrine [Moles/time] in 24 hour Urine

104

1.06

0.01

1.4

1.2

0.76

0.70

umol/24h

—

(3014051) Protein [Presence] in Urine by Test strip

135

1344

1.00

0.00

3.7

2.7

—

(3006270) Folate [Moles/volume] in Blood

455

1.01

0.00

1.2

272.20

337.18

nmol/l

1.52

362

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.03

0.00

1.7

1.5

163.90

151.89

ng/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

183

0.98

0.00

1.1

1.4

1.66

1.56

g/l

0.59

183

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

207

1.01

0.00

1.4

1.3

6.06

6.15

mmol/l

0.13

194

(3000034) Microalbumin [Mass/volume] in Urine

496

1.01

0.00

2.4

3.2

61.80

47.70

mg/l

0.20

380

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

129

1.01

0.00

2.1

2.3

7.98

8.31

mmol/l

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.90

0.00

1.0

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

10.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3022689) Creatine [Moles/volume] in Urine

130

1.00

-0.00

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.88

-0.00

1.0

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.1

—

2825.71

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.2

—

0.30

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

1.85

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1478.75

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.28

—

(3002619) Bacteria identified in Specimen by Culture

0.91

-0.00

1.5

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ILD_HOSPITAL_MAIN – ILD, hospital admissions 1, main diag only

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

ILD, hospital admissions 1, main diag only

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for ILD, hospital admissions 1, main diag only (ILD_HOSPITAL_MAIN)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints